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DISSERTATION ABSTRACT 
 
Matthew D. Hammers 
 
Doctor of Philosophy 
 
Department of Chemistry and Biochemistry 
 
June 2016 
 
Title: The Development of Fluorescent Probes and Slow-Releasing H2S Donors for 
Studying Biological H2S 
 
 
Hydrogen sulfide (H2S) is an essential small molecule in human physiology. 
Although quite toxic, H2S is produced endogenously and performs important regulatory 
functions in the cardiovascular, immune, nervous, and respiratory systems. Varied 
interactions with intracellular thiols, reactive oxidants, and protein transition-metal 
centers are highly dynamic and sensitive to fluctuations in redox homeostasis. 
Furthermore, H2S is implicated in a number of diseases such as cancer, 
neurodegeneration, and heart disease. Hence, exogenously delivered H2S as a therapeutic 
agent is an active area of intrigue and research. The complexity and interconnectivity of 
these processes has stimulated the development of advanced chemical tools with which to 
study biological H2S, including reaction-based fluorescent probes and slow-releasing H2S 
donors.  
Toward these goals, I present several significant advances in the fields of H2S 
detection and delivery. An azide reduction-based probe, MeRho-Az, provides a rapid 
>1,000-fold fluorescence response when treated with H2S. MeRho-Az is sufficiently 
sensitive to detect endogenous H2S in C6 cells and was used to image H2S in live 
 v 
 
zebrafish larvae using light sheet fluorescence microscopy, representing the first analyte-
responsive experiments with this imaging technology. Using a ratiometric dual-
fluorophore fragmentation strategy, NBD-Coum simultaneously detects, differentiates, 
and measures relative concentration ratios of H2S versus cysteine/homocysteine, two 
important metabolites in H2S biosynthesis. NBD-Coum was used to monitor changes in 
redox homeostasis in a simulated sulfur pool and is useful for studying H2S-thiol 
dynamics. The synthesis and amide-coupling conditions of ADT-NH2, a highly sought 
dithiolethione H2S donor, allow for hydrolytically stable, H2S-releasing non-steroidal 
anti-inflammatory drug hybrids. Finally, inspired by polysulfide-containing natural 
products, functionalized tetrasulfides are a new class of accessible, customizable, and 
versatile H2S donors with controllable H2S release rates. I hope that by using these 
investigative tools, chemists and biologists are able to refine our understanding of 
physiological H2S and exploit H2S activities in disease treatments. 
This dissertation includes previously published and unpublished coauthored 
materials. 
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CHAPTER I 
INTRODUCTION 
 
 Sulfur is an essential element for executing the human body’s operational plan. In 
proteins, cysteine (Cys) amino acid thiols participate in enzymatic operations as a 
nucleophile, and oxidation of cysteine residues to form disulfide bridges help maintain 
the integrity of tertiary protein structure. Glutathione (GSH), a common Cys-containing 
tripeptide often present at up to 5 mM concentrations in the body, is an important 
antioxidant protecting cellular environments from harmful reactive oxygen and nitrogen 
species. Finally, hydrogen sulfide (H2S), which contains fully reduced sulfur, performs 
signal transduction operations throughout the body, notably in heart, brain, and liver 
tissues. The rich chemical biology associated with physiological sulfur continues to 
evolve with our understanding of how these molecules interact among themselves and 
with other cellular machinery. To better facilitate research into these areas and to situate 
H2S within this context, advanced chemical tools and methodologies are being developed 
for H2S detection and delivery which provide important spatial and temporal information 
in both in vitro and in vivo experiments. 
 The perception of H2S has been transformed from existing as merely a toxic, 
odorous environmental pollutant.  This important small molecule is now recognized as an 
essential mammalian gasotransmitter, meaning H2S is an endogenously produced gaseous 
signaling molecule with regulated biosynthetic, translocation, and metabolic pathways.
1-4
 
H2S is generated enzymatically from Cys and homocysteine (Hcy) feedstocks primarily 
2 
 
by the enzymes cystathionine β-synthase (CBS),5 cystathionine γ-lyase (CSE),6 and 3-
mercaptopyruvate sulfurtransferase (3-MST) (Figure 1.1).
7
 The rate of H2S biosynthesis 
is sensitive to concentration fluctuations of any of these feedstocks, and thus these 
pathways are tightly regulated. Generated H2S then exerts regulatory influence in a 
number of systems within the body.
4
 In the cardiovascular system, H2S interacts with 
KATP channels and modulates vasorelaxation, angiogenesis, and cell 
proliferation/apoptosis.
8-11
 H2S elicits either pro- or anti-inflammatory responses in the 
immune system depending on experimental conditions, which is an intriguing and 
controversial aspect of current H2S research.
12-15
 H2S is a neuromodulator, and its 
stimulation of NMDA receptors induces hippocampal memory formation in the central 
nervous system (CNS).
1,16
 Furthermore, CNS diseases such as Alzheimer’s and 
Parkinson’s disease, as well as Down syndrome have been linked with abnormal H2S 
production levels.
17-19
 Much of the toxicity associated with H2S is due to its effects on the 
respiratory system, where H2S can inhibit cytochrome c oxidase and disrupt the electron 
transport chain in mitochondria.
20
 The complexity and interconnectivity of these varied 
physiological implications require that advanced tools and technologies for H2S detection 
be developed to differentiate the activities of H2S from other biologically relevant 
analytes and to truly refine our understanding of physiological H2S. 
 Although there is substantial evidence establishing the importance of H2S in 
biology, historically the main challenge to fully elucidating its role has been a lack of 
detection and quantification methods that provide sufficient sensitivity, selectivity, in 
vivo compatibility, and ease of use. Because of this challenge, estimations of 
physiological H2S levels have varied widely, over a five order of magnitude range.
21
 
3 
 
 
Figure 1.1. Endogenous biosynthesis and signaling targets of H2S. 
 
Until recently, the two most commonly used methods for H2S detection and 
quantification have been the methylene blue (MB)
22
 and monobromobimane (MBB)
23
 
assays (Figure 1.2a). In the MB assay, an experimental sample is treated with Zn(OAc)2 
and p-dimethylaminoaniline under acidic conditions to form methylene blue, which has a 
characteristic absorbance at 670 nm. Unfortunately, the harshly acidic conditions present 
in the MB workup liberate acid-labile sulfur from sources such as iron-sulfur clusters, 
which limits the selectivity of this method.
23
 Alternatively, the MBB assay improves 
upon this limitation by analyzing the reaction products of an experimental sample with 
monobromobimane using fluorescence HPLC. H2S undergoes nucleophilic substitution 
with two equivalents of monobromobimane to form sulfide-dibimane (SdB). SdB is 
fluorescent at 478 nm and can be quantified. Furthermore, a more elaborate workflow 
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used in concert with this strategy is able to differentiate sulfide from among different 
sulfur pools including free, sulfane, and acid-labile sulfide.
24
 Homogenization of 
experimental tissue samples is required using either the MB or MBB assays, however, 
which precludes any live-cell or -animal imaging experiments. Other more classical 
technologies such as gas chromatography, polarography, and H2S-selective electrodes 
also have similar limitations in sensitivity, response rate, selectivity, and/or require 
complex workups.
25-27
 To overcome these challenges in H2S detection, chemists have 
shifted their focus toward developing new methodologies including fluorescence 
detection. 
   
 
Figure 1.2. a) Traditional methods for H2S detection including the methylene blue and 
monobromobimane assays. b) Fluorescence detection strategies for H2S including double 
nucleophilic attack, copper (II) sulfide precipitation, and azide reduction. 
5 
 
 
 Reaction-based, small-molecule fluorescent probes provide a number of 
advantages over previously developed H2S detection strategies. Fluorescence detection 
experiments using these probes do not require harsh reaction conditions or tissue 
destruction for effective H2S visualization and are thus amenable to both live-cell and in 
vivo environments. Furthermore, fluorescence imaging techniques may be performed 
with real-time spatiotemporal resolution. As chemists explore fluorescence-based H2S 
detection, there are several important requirements to consider. The probe must react 
rapidly with H2S, generate a strong and sensitive fluorescence response, and exhibit 
excellent selectivity for H2S over other biologically relevant analytes (Cys and GSH in 
particular).  
Toward these goals, three main reaction-based strategies (Figure 1.2b) have been 
developed which exploit unique characteristics of H2S reactivity: utilizing 1) the dual-
nucleophilicity of H2S to liberate an ester-bound fluorophore adjacent to a nearby 
electrophilic site through an initial nucleophilic attack and successive intramolecular 
cyclization, 2) the propensity of H2S to form insoluble salts with metal cations to 
precipitate CuS from Cu
II
-ligated fluorophores, and 3) the reducing power of H2S to 
reduce azide-modified fluorophores and regenerate their respective fluorogenic amines. 
In each of these strategies, a fluorophore is structurally modified such that its 
fluorescence is quenched. Reaction with H2S removes this quenching mechanism and 
results in a fluorescence turn-on. This topic has been reviewed extensively,
28-39
 and the 
reader is directed to Chapters II and III for additional discussion. Of these fluorescence-
6 
 
based H2S detection strategies, azide reduction has been the most broadly applied, partly 
due to the ease of azide functionalization of amine-containing fluorophores and the 
plethora of amine-containing fluorophores from which to functionalize. As such, this 
strategy has been extended to include over 70 fluorophore scaffolds in only the past 
several years. Taken together, the advent of reaction-based fluorescent probes for H2S has 
provided chemical biologists with a new class of tools with which to perform live-cell 
and in vivo experiments not possible using previously developed assays. With the added 
knowledge that these experiments provide, scientists look toward application-driven 
development of new research tools. 
As we refine our understanding of the physiological roles of H2S, it becomes clear 
that H2S activity and disease are closely related. Therefore, there is motivation for 
chemists to construct synthetic donor molecules that deliver ‘caged’ H2S into biological 
systems within the context of therapeutic application for diseases such as cancer, 
inflammation, neurodegeneration, heart disease, and HIV (Figure 1.3).
13,40-43
 Injecting 
H2S gas or its sodium salt, NaHS, into a biological system results in an immediate, large 
burst of H2S; however, and the abrupt homeostatic perturbation likely has erroneous 
effects unrelated to the specific H2S activity of interest. Delivering H2S in a more 
controlled manner akin to endogenous production rates would be more advantageous 
when isolating cause and effect relationships. Several classes of slow-releasing H2S 
donors have been developed for this purpose,
42,43
 including dithiolethione-containing 
compounds such as ADT-OH, phosphinodithioate GYY4137, thiol-mediated N-
mercaptobenzamides and perthiols, light-activated geminal dithiols, and even 
polysulfide-containing natural products. Many of these compounds have been 
7 
 
investigated for their therapeutic potential. In particular, ADT-OH has been investigated 
in conjunction with bound non-steroidal anti-inflammatory drugs (NSAIDs) for their 
synergistic antioxidant and anti-inflammatory activities. It has been functionalized with a 
number of NSAIDs through ester linkages, such as aspirin and naproxen,
44,45
 and several 
of these H2S-donating NSAIDs are in clinical trials.
46
 GYY4137 has also been 
investigated extensively in cancer and cardiovascular disease research.
47
 The reader is 
directed to Chapters IV and V for additional discussion of these compounds and their 
application in drug therapeutics. Overall, the observed physiological effects of H2S often 
vary significantly depending upon which H2S donor is used in the experiment, and 
judicious selection of H2S donor appears essential to eliciting a desired physiological 
response. 
 
 
Figure 1.3. Synthetic H2S donors deliver caged sulfide for the treatment of a number of 
diseases, including inflammation, neurodegeneration, cancer, heart disease, and HIV. 
 
 In this dissertation, I have created and investigated chemical tools for assisting 
chemists, biochemists, and biologists in their study of the two main areas of H2S 
research: identifying the physiological roles of H2S and utilizing exogenous H2S in drug 
Inflammation
Cancer
HIV
Heart Disease
Neurodegeneration
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therapeutic applications. In Chapters II and III, I describe the development of an azide-
reduction strategy for H2S detection which represents the strongest fluorescence response 
reported to date and a dual-fluorophore fragmentation system which simultaneously 
detects and differentiates H2S and Cys/Hcy. Then in Chapters IV and V, I present the 
synthesis and amide-coupling of ADT-NH2 with various NSAIDS which exhibits 
significantly improved hydrolytic stability over ester-bound analogs and tetrasulfides as a 
new easily-accessible class of H2S donors.  
These chapters include both previously published and unpublished coauthored works 
of the following: 
CHAPTER II: A BRIGHT FLUORESCENT PROBE FOR H2S ENABLES 
ANALYTE-RESPONSIVE, 3D IMAGING IN LIVE ZEBRAFISH USING LIGHT 
SHEET FLUORESCENCE MICROSCOPY  
- Hammers, M. D.; Taormina, M. J.; Cerda, M. M.; Montoya, L. A.; 
Seidenkranz, D. T.; Parthasarathy, R.; Pluth, M. D. J. Am. Chem. Soc. 2015, 
137, 10216-10223. 
- Co-authors: Michael J. Taormina, Matthew M. Cerda, Leticia A. Montoya, 
Daniel T. Seidenkranz, Rahuveer Parthasarathy, and Michael D. Pluth 
CHAPTER III: RATIOMETRIC MEASUREMENT OF H2S AND 
CYSTEINE/HOMOCYSTEINE RATIOS USING A DUAL-FLUOROPHORE 
FRAGMENTATION STRATEGY 
- Hammers, M. D.; Pluth, M. D. Anal. Chem. 2014, 86, 7135-7140. 
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- Coauthors: Michael D. Pluth 
CHAPTER IV: SYNTHESIS OF AMINO-ADT PROVIDES ACCESS TO 
HYDROLYTICALLY-STABLE AMIDE-COUPLED H2S-RELEASING DRUG 
TARGETS 
- Hammers, M. D.; Singh, L.; Montoya, L. A.; Moghaddam, A. D.; Pluth, M. 
D. Synlett 2016, eFirst online. [DOI: 10.1055/s-0035-1560603]. 
- Coauthors: Loveprit Singh, Leticia A. Montoya, Alan D. Moghaddam, 
Michael D. Pluth 
CHAPTER V: FUNCTIONALIZED TETRASULFIDES AS EASILY 
ACCESSABLE H2S DONORS 
- Unpublished, manuscript in preparation 
- Coauthors: Mary S. Earp, Michael D. Pluth 
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CHAPTER II 
A BRIGHT FLUORESCENT PROBE FOR HYDROGEN SULFIDE ENABLES 
ANALYTE-RESPONSIVE, 3D IMAGING IN LIVE ZEBRAFISH USING LIGHT 
SHEET FLUORSCENCE MICROSCOPY 
 
This work includes previously published and coauthored material from Hammers, M. D.; 
Taormina, M. J.; Cerda, M. M.; Montoya, L. A.; Seidenkranz, D. T.; Parthasarathy, R.; 
Pluth, M. D. J. Am. Chem. Soc. 2015, 137, 10216-20223. 
 
Introduction 
The perception of hydrogen sulfide (H2S) in the scientific community has shifted 
dramatically in the 21
st
 century.
4
 No longer viewed as merely a toxic geological and 
environmental pollutant, H2S is now at the center of a rich and expanding field focused 
on investigating its biological and physiological significance. Since 1996, when Abe and 
Kimura first suggested that H2S acts as a neuromodulator in hippocampal long-term 
potentiation,
1
 H2S has been recognized as an essential gasotransmitter that regulates 
many important physiological functions in the cardiovascular, nervous, endocrine, 
immune, and gastrointestinal systems.
4,8,16,48-50
 Biosynthesized by three main enzymes, 
cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate 
sulfurtransferase (3-MST), H2S is generated enzymatically in the heart, brain, liver, and 
kidneys; however, localized H2S concentrations in the body are tissue-dependent, 
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suggesting differential activation and action in various H2S-producing pathways.
51
 Once 
generated, H2S undergoes complex catabolism through its interactions with cellular 
oxidants, protein transition-metal centers, and reactive sulfur, oxygen, and nitrogen 
species (RSONs), all of which are sensitive to internal and external redox stimuli. For 
example, oxidative S-sulfhydration (or persulfidation) of protein cysteine residues is 
proposed to constitute a significant sulfide storage mechanism, which modifies protein 
function and the signaling activity of H2S.
52-55
 The intricacy of physiological H2S 
reactivity requires that researchers utilize advanced chemical and technological tools for 
H2S detection and imaging in order to gain a more detailed understanding of the 
interconnectivity of these networks. 
In recent years chemists have answered the call for improved tools for H2S 
detection by developing small-molecule fluorescent probes and similar methods to 
investigate biological H2S.
28,56
 Historically the most widely utilized assay for H2S 
detection and quantification has been the methylene blue assay.
22
 This technique, 
however, requires sample homogenization and a harshly acidic workup that precludes 
real-time detection or live-animal imaging. These conditions also liberate sulfur from 
acid-labile sulfur pools and are thus not selective for H2S.
24
 By contrast, H2S 
quantification using monobromobimane (mBB) has better detection limits and enables 
separation of free, sulfane, and acid-labile sulfide pools.
23
 Although the mBB method 
offers a robust platform for H2S quantification, this technique still requires sample 
destruction and additional HPLC analysis. Similarly, the usefulness of other techniques 
including gas chromatography and sulfur-selective electrodes are limited by complex 
workups and/or insufficient sensitivity.
25,27
 Alternatively, reaction-based fluorescent 
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probes offer the potential for in vivo compatibility, high sensitivity, and high 
spatiotemporal resolution while maintaining selectivity for H2S over other RSONs 
including free thiols, which are abundant in much higher concentrations than H2S in 
cellular milieu. Based on these requirements, three main reaction-based strategies for H2S 
imaging have been developed: using the dual-nucleophilicity of H2S to liberate ester-
bound fluorophores with nearby reactive electrophilic sites,
57-63
 formation and 
displacement of CuS from Cu
II
-ligated fluorophores,
64-66
 and reduction of nitro- and 
azide-functionalized fluorophores.
67-82
 Among these strategies, H2S-mediated azide 
reduction has been the most broadly reported due to the plethora of amine-functionalized 
fluorophores available for modification and the ease of azide functional group 
installation. Azide reduction is often rapid and produces large (10–100-fold) fluorescence 
turn-ons, with the resultant probes exhibiting functional low micromolar detection limits 
and excellent selectivity profiles. One limitation of such methods, however, is the 
potential photoreduction of azides to amines, which can lead to unwanted photoactivation 
in long-term imaging experiments.
76
  
Despite the rapidly-advancing progress in H2S probe development, few examples 
of live-animal imaging and application of these tools in biological studies exist
80,83-85
 due 
to the substantial challenges associated with transitioning from cell culture to whole 
organisms. Additionally, the innate sensitivity of fluorophores to high energy excitation 
must be considered against tissue penetration requirements for in vivo imaging, thus 
complicating problems with azide photoactivation. Laser scanning confocal microscopy, 
a popular technique in three-dimensional fluorescence imaging, inherently sacrifices 
illumination efficiency in order to achieve highly resolved, focused images. This process 
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often results in photobleaching (or photoactivation). An alternative imaging strategy with 
significantly reduced photobleaching and phototoxicity by comparison to confocal or 
even 2-photon illumination is light sheet fluorescence microscopy (LSFM), in which 
excitation light is confined to a thin sheet coinciding with the focal plane of a wide field 
imaging system.
86-90
 LSFM also provides access to significantly larger samples (> 1 mm) 
than conventional confocal microscopy, while maintaining fast imaging times. 
Highlighting the impact of this emerging imaging technique, LSFM of larval zebrafish, a 
useful model for many aspects of vertebrate development,
91
 enables the imaging of 
intestinal tract contents with three-dimensional spatial resolution of microns, temporal 
resolution of seconds, and durations of tens of hours. Such contents can include bacterial 
communities colonizing the gut of the fish, a particularly interesting target for future 
investigations of microbial sulfur metabolism and the role of H2S and associated sulfur-
containing species in gut microbiota.
92,93
 A key unmet step toward bridging this gap, 
however, is the utilization of analyte-responsive imaging tools in combination with 
LSFM. Combining these application-driven approaches would enable significant new 
avenues of investigation, such as small-molecule and secondary messenger trafficking, by 
providing access to real-time, analyte-responsive imaging in whole organisms. Toward 
this goal, we report herein the development of a bright fluorescent probe for selective 
H2S imaging and demonstrate for the first time analyte-responsive detection experiments 
in combination with LSFM in live zebrafish. Supplemental information can be found in 
Appendix A. 
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Results and Discussion 
Because of the small sample volume excited during LSFM experiments, a high 
dynamic range and a bright fluorophore are key probe requirements for analyte detection 
studies. Although fluorescein and rhodamine are common platforms in the design of 
reaction-based probes because of their excellent photophysical properties, including high 
extinction coefficients and quantum yields,
94
 their susceptibility to photobleaching and 
pH sensitivity can limit their versatility in certain biological environments. Additionally, 
although reaction-based probes for H2S detection based on azido-fluorescein or 
rhodamine conjugates have provided useful tools for investigations of H2S in context,
67,79
 
the dynamic range of these scaffolds (typically < 25-fold turn-on) remains insufficient for 
LSFM investigations. To overcome these limitations, we reasoned that the rhodol (or 
rhodafluor) family of fluorophores would provide an attractive platform well suited for 
LSFM with improved pH insensitivity and photostability, while retaining many of the 
key photophysical advantages of their parent structures.
95
 Additionally, O-alkylation of 
rhodols provides a potential handle for structural modification, and unlike fluorescein, O-
alkylation typically does not appreciably mitigate the quantum yield. Consequently, 
rhodol derivatives have been adopted as sensors for hydrogen peroxide, hydrolase 
activity, nitroxyl, and thiols in recent years.
96-99
 We envisioned that an O-methylrhodol 
(MeRho) modified by an azide-functionalized xanthene core (MeRho-Az) would be 
locked in a non-fluorescent spirocyclic lactone tautomer. H2S-mediated azide reduction 
would unmask fluorophore fluorescence by regenerating the amine and unlocking the 
fluorescent open tautomer (Scheme 2.1). Given the inherent brightness of rhodols and the 
rapidity of H2S-mediated azide reduction, we reasoned that MeRho-Az would produce a 
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strong fluorescent response to H2S when reduced, thus providing a high fidelity 
functional tool for studying H2S in vivo that is compatible with LSFM. 
 
 
Scheme 2.1. Synthesis and H2S-mediated activation of MeRho-Az. 
 
 To test this design hypothesis, we first prepared the rhodol scaffold by adapting 
the modular rhodol synthesis reported by Yang and co-workers
100
 to convert 
methylfluorescein (1) to MeRho in two steps. Triflation of 1 with N-phenyl-
bis(trifluoromethanesulfonamide) to form triflated methylfluorescein (2), and subsequent 
Buchwald-Hartwig amination with benzophenone imine as an ammonia equivalent, 
followed by acid hydrolysis, affords MeRho in 84% overall yield. During reaction 
optimization, we found that initially heating the amination reaction to 140 °C increased 
the yield significantly, presumably by either facilitating efficient formation of the L–Pd0 
active catalyst or by accelerating oxidative addition of 2. Finally, diazotization of MeRho 
and azidification under Sandmeyer conditions affords MeRho-Az. 
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With both MeRho and MeRho-Az in hand, the photophysical properties of each 
compound were characterized (Table 2.1). MeRho displays excellent solubility in 
aqueous buffer (50 mM PIPES, 100 mM KCl, pH 7.4), with absorption and fluorescence 
bands centered at 476 nm and 516 nm, respectively (Figure A.1). As predicted, MeRho 
exhibits a high quantum yield (ΦMeRho = 0.57), whereas the quantum yield of the closed 
lactone form of MeRho-Az is essentially zero when excited at either the λmax (286 nm) or 
that of MeRho (476 nm). To establish the fidelity of the MeRho scaffold under 
physiological conditions, we investigated the pH-dependent fluorescence. By performing 
a pH titration and monitoring the fluorescence, we established that the MeRho 
fluorophore maintains a constant emission between pH 4.5 and 10 (Figure 2.1), with 
apparent pKa values of 3.3 and 12.2, making the biologically viable pH range superior to 
that of fluorescein (Figure A.2). Additionally, the MeRho fluorophore maintains 75% of 
its maximum fluorescence under highly-acidic conditions. 
 
 
 
Table 2.1. Spectroscopic properties of MeRho and MeRho-Az in PIPES buffer (50 mM, 
100 mM KCl, pH 7.4). Quantum yield are presented relative to fluorescein (0.1 M 
NaOH). 
 
Having established that MeRho offers a bright, biocompatible fluorophore 
platform, we next investigated the viability of MeRho-Az as a fluorescent H2S sensor. 
MeRho-Az (5 µM) exhibits a rapid increase in fluorescence when treated with 50 equiv. 
 
λmax (nm) ε (M
-1
 cm
-1
) λem (nm) ɸ 
MeRho 476 30,800 516 0.57 
MeRho-Az 286 13,900 N/A < 0.01 
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of NaHS (250 µM) in aqueous PIPES buffer (50 mM, 100 mM KCl, pH 7.4). Owing to 
the stark contrast in brightness between the azide- and amine-functionalized rhodol 
scaffolds, reduction of MeRho-Az to the parent amine produces a 1200-fold fluorescence 
turn on (F/F0) over 60 minutes (440-fold without any background correction) (Figure 
2.2a). This represents one of the strongest fluorescent responses from H2S detection 
recorded to date. 
 
Figure 2.1. Integrated MeRho fluorescence (20 µM, λex = 476 nm, λem = 480-650 nm) in 
aqueous solution at various pH (100 mM KCl).  
 
While the reaction of some probes with H2S may reach completion more quickly, the 
magnitude of response with MeRho-Az after merely five minutes is significant. 
Furthermore the fluorescence turn-on characteristics of MeRho-Az are faster and stronger 
than a recently reported nitro-reduction rhodol platform,
101
 which is consistent with 
previous findings from our group in which azide reduction on a naphthalimide scaffold 
proceeds faster and has a stronger turn-on than the corresponding nitro-functionalized 
analogue.
102
 After determining that MeRho-Az effectively reports on H2S, the sensitivity 
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and detection limit of the probe was examined. A linear, concentration-dependent 
fluorescence relationship was observed between MeRho-Az fluorescence and increasing 
H2S concentrations (Figure 2.2b, Table A.1). The detection limit was calculated to be the 
concentration at which the fluorescence equals that of [blank + 3σ] according to a linear 
regression fit of the data and determined to be 86 ± 7 nM. Supporting the validity of this 
detection limit, the MeRho-Az probe can differentiate between 1.0 and 0.10 µM H2S with 
a p value < 0.01. Finally, to test the photostability of MeRho-Az, we prepared three 
common azide-based H2S detection probes HSN2, DNS-N3, and C7-Az,
68,77,102
 which are 
based on naphthalimide, dansyl, and coumarin fluorophores, respectively, and compared 
the photoactivation of each azide under identical conditions in the absence of H2S. As 
expected, the rhodol system in MeRho-Az exhibits significantly less photoactivation than 
the other azide-based systems (Figure 2.2c). Taken together, these data demonstrate the 
reactivity of MeRho-Az with H2S and highlights its sensitivity and potential for use in 
biological applications. 
After establishing the concentration-dependent reactivity for MeRho-Az with 
H2S, we examined the reactivity of various RSONs toward the probe to establish a 
selectivity profile (Figure 2.3). No fluorescence was observed upon introduction of 50 
equiv. (250 µM) of biological thiols cysteine (Cys), homocysteine (Hcy), or glutathione 
(GSH) over 60 minutes. Sulfur anions thiosulfate, (S2O3
2–
), sulfite (SO3
2–
), and sulfate 
(SO4
2–
), as well as hydrogen peroxide (H2O2) and nitric oxide (NO) also all proved to be 
chemically inert toward the probe. Additionally, MeRho-Az exhibits 32-fold preferential 
reactivity with H2S relative to 5 mM GSH loading, thus reinforcing the excellent 
selectivity of the H2S-mediated azide-reduction mechanism. 
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Figure 2.2. a) Uncorrected fluorescent response of MeRho-Az to NaHS treatment over 
60 minutes. Conditions: 5 µM MeRho-Az, 250 µM NaHS, PIPES buffer (50 mM, 100 
mM KCl, pH 7.4), λex = 476 nm, λem = 480-650 nm, 37 °C. b) Concentration-dependent 
fluorescence of MeRho-Az when treated with 0.10, 2.5, 5.0, 7.5, and 15 µM NaHS and 
incubation for 90 minutes at 37 °C. Each data point represents the average of at least 
three trials. Error bars were calculated as standard deviation. c) Fluorescence 
photoactivation response of HSN2 (λex = 432 nm, λem = 542 nm), DNS-N3 (λex = 340 nm, 
λem = 550 nm), C7-Az (λex = 340 nm, λem = 445 nm), and MeRho-Az (λex = 476 nm, λem = 
516 nm). Excitation slits: 2.6 nm. Data measured at 4 s
-1
. 
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Figure 2.3. Selectivity profile of MeRho-Az toward reactive sulfur, oxygen, and nitrogen 
species. From left to right: blank, NaHS, L-cysteine, DL-homocysteine, glutathione, 
Na2S2O3, Na2SO3, Na2SO4, H2O2, and DEA NONOate. Conditions: 5 µM MeRho-Az, 
250 µM RSONs, PIPES buffer (50 mM, 100 mM KCl, pH 7.4), λex = 476 nm, λem = 480-
650 nm, 37 °C. Data were acquired after 60 minute incubation at 37 °C. 
 
Based on the excellent H2S sensing properties of MeRho-Az, we sought to 
establish the efficacy of MeRho-Az for detecting endogenously produced H2S in cells. 
After incubation of C6 rat glial cells, which express the H2S-producing CBS enzyme, 
with 5 µM MeRho-Az for 45 minutes, the cells were fixed and imaged using a 
fluorescence microscope (Figure 2.4). We then compared this fluorescence response with 
cells that had been pretreated with either a slow-releasing H2S donor (AP39, 100 nM)
103
 
or a common CBS inhibitor (aminooxyacetic acid, AOAA, 20 µM).
104
 We observed a 
significant reduction in fluorescence in cells treated with AOAA by contrast to untreated 
cells, suggesting that MeRho-Az is sufficiently sensitive to detect endogenous levels of 
enzymatically-produced H2S. Furthermore, cells treated with low concentrations of AP39 
showed enhanced fluorescence, highlighting the sensitivity of the system. These results 
demonstrate the applicability of the MeRho-Az platform in cellular environments, which 
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can likely be extended to assays involving biological fluids such as serum, blood, or 
tissue homogenates. 
 
 
Figure 2.4. Fluorescence imaging of H2S in C6 cells. Cells were imaged after incubation 
with 5 µM MeRho-Az for 45 minutes after pretreatment with a) no pretreatment, b) 100 
nM AP39 for 60 minutes, or c) 20 µM AOAA for 45 minutes. Scale bars = 5 µm. d) 
Quantified cellular fluorescence after reaction of MeRho-Az with endogenous H2S 
(MeRho-Az, N=3), after addition of exogenous H2S (AP39, N=3), and after inhibition of 
enzymatic H2S production (AOAA, N=3). 
 
To further establish MeRho-Az as an in vivo H2S reporter, we next examined its 
biocompatibility using LSFM. Because little is known about endogenous sulfide 
dynamics in developing zebrafish, we focused our initial efforts on H2S release from a 
commonly used slow-releasing H2S donor, diallyl trisulfide (DATS). To confirm, as 
previously reported, that a thiol such as GSH is required to achieve H2S release from 
DATS,
105
 we used MeRho-Az with DATS to detect liberated H2S and observed a dose-
dependent release of H2S in response to [GSH] (Figure A.3). To expand on the use of 
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MeRho-Az and to establish its validity for use with LSFM in live organisms, we chose to 
use larval (7 days post fertilization) zebrafish for imaging studies. At this stage in their 
development, zebrafish are approximately 3 mm in length and maintain a high level of 
transparency. Also, a key benefit of LSFM is that the collection of illuminated sheets that 
make up the three-dimensional images is obtained on a time scale (~10 seconds in total) 
significantly faster than the timescale of gut peristalsis (~ 1 min), which allows for direct 
analysis of the actual gut volume with minimal artifacts from translational movement. 
We first tested the toxicity of MeRho-Az in larval zebrafish by orally gavaging
106
 7 nL of 
buffered solutions (50 mM PIPES, 100 mM KCl, pH 7.4) containing 5 µM MeRho-Az, 
and monitored the fish over time. No toxicity was observed for 20 hours, and although 
this cannot completely rule out unwanted biological effects in longer term experiments, it 
suggests the safe use of MeRho-Az as a viable in vivo fluorescent reporter over the time 
scale of hours. To test the ability of MeRho-Az to provide an analyte-responsive signal 
toward H2S, larval zebrafish were orally gavaged with buffered solutions containing: 
buffer only, 5 µM MeRho-Az, 5 µM MeRho-Az + 250 µM DATS, 5 µM MeRho-Az + 
250 µM DATS + 250 µM GSH, or 5 µM MeRho. After 60 minutes of recovery time, a 
three dimensional image of the intestinal bulb for each fish was acquired using LSFM 
(Figure 2.5). 
No difference in fluorescence was observed when comparing the signal between a 
vehicle-gavaged control group and fish gavaged with either MeRho-Az alone or MeRho-
Az + DATS, confirming that LSFM was not causing photoactivation of the azide and that 
H2S release from DATS was GSH-dependent (Figure 2.6). By utilizing a control of 
buffer-gavaged fish instead of un-gavaged fish, the relative strength and variability of  
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Figure 2.5. 2D slices of LSFM images of live zebrafish 60 minutes after gavage. a) 
Larval zebrafish (7 dpf) gavaged with phenol red to highlight the intestine (scale bar = 1 
mm). The boxed region corresponds to the intestinal bulb expanded below in b,c). 
Zebrafish gavaged with b) 5 µM MeRho-Az + 250 µM DATS + 250 µM GSH or c) 5 µM 
MeRho-Az. Scale bar in b) and c) = 10 µm.  
 
mucosal autofluorescence is suppressed. Additionally, any morphological changes to the 
gut cavity upon gavage are accounted for in buffer-gavaged fish. In contrast, fish gavaged 
with MeRho-Az and DATS/GSH were measurably brighter than the vehicle or MeRho-
Az alone (Figure 2.6), confirming that H2S was being captured by MeRho-Az and 
visualized using LSFM (Figure 2.5, see DOI: 10.1021/jacs.5b04196 for a link to video 
compiling 2D image slices into a 3D representation). To compare the relative intensity of 
the fully activated probe, we also gavaged fish with the fluorophore, MeRho, alone, 
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which resulted in an identical intensity to that observed with MeRho-Az with 
DATS/GSH, which is consistent with efficient H2S-mediated activation of MeRho-Az in 
the zebrafish gut. To the best of our knowledge, these data demonstrate the first use of 
analyte-responsive reaction-based probes in live-animal imaging experiments using 
LSFM, thus opening the door for new investigations of whole-organism imaging in the 
context of reactive small molecule analytes. In a broader context, the three-dimensional 
imaging capability afforded by LSFM is crucial for accurately determining fluorescence 
intensity in a whole organism due to the heterogeneity of basal autofluorescence, 
reflection, and absorption of various tissues and organs. Differentiation and separation of 
these different signals would not be possible without the 3D intensity map afforded by 
LSFM imaging. 
 
 
Figure 2.6. Average fluorescence intensity in zebrafish intestinal bulb, normalized to the 
mean of the buffer-gavaged set. Each dot represents one fish, each of which provided 
~10
7
 intensity measurements. Boxes extend to the first and third quartile; whiskers 
enclose data within 1.5 times the inter-quartile range. Solid lines denote median, and 
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dashed lines denote mean values. Shown are measurements for fish orally gavaged with 
6.9 nL of buffered solutions (50 mM PIPES, pH 7.4): buffer (N=5), 5 µM MeRho-Az 
(N=9), 5 µM MeRho-Az + 250 µM DATS (N=8), 5 µM MeRho-Az + 250 µM DATS + 
250 µM GSH (N=8), and 5 µM MeRho (N=6). 
 
Conclusion and Bridge 
 
 Motivated by enabling new whole-animal imaging techniques for H2S, we have 
developed a bright, selective fluorescent probe for H2S detection based on a rhodol 
platform and demonstrated its application both in cells and in LSFM experiments with 
live zebrafish. This new application of LSFM for use with reaction-based analyte-
responsive probes is enabled by the large dynamic range, high photostability, and 
excellent selectivity afforded by MeRho-Az and would not have been possible with 
previously-reported H2S sensing systems.  
In addition to the fluorescence detection of H2S, we’ve also developed a strategy 
for studying H2S-thiol dynamics by fluorescence. By using a dual-fluorophore 
fragmentation strategy, we’re able to simultaneously detect and determine relative 
concentration ratios of H2S relative to Cys/Hcy. This strategy will be described in its 
entirety in Chapter III. 
 
Experimental 
 
Materials and methods. Reagents were purchased from Sigma-Aldrich or Tokyo 
Chemical Industry (TCI) and used as received. Methylfluorescein (1), HSN2, DNS-N3, 
and C7-Az were synthesized as reported previously.68,77,102,103,107 Deuterated solvents 
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were purchased from Cambridge Isotope Laboratories and used as received. Silica gel 
(SiliaFlash F60, Silicycle, 230 - 400 mesh) was used for column chromatography. 
Preparatory chromatography was performed on Silicycle SiliaPlates (1 mm thickness). 1H 
and 13C{1H} NMR spectra were recorded on a Varian INOVA 500 MHz NMR 
instrument. Chemical shifts are reported in ppm relative to residual protic solvent 
resonances. UV–visible spectra were acquired on a Cary 100 spectrometer equipped with 
a Quantum Northwest TLC-42 dual cuvette temperature controller at 37.00 ± 0.05 °C. 
Fluorescence spectra were obtained on a Quanta Master 40 spectrofluorometer (Photon 
Technology International) equipped with a Quantum Northwest TLC-50 temperature 
controller at 37.0 ± 0.05 °C.  
Spectroscopic materials and methods. Piperazine-N,N′-bis(2-ethanesulfonic 
acid) (PIPES) and potassium chloride (99.999%) were used to make buffered solutions 
(50 mM PIPES, 100 mM KCl, pH 7.4) in Millipore water. Buffer solutions were sparged 
with N2 to remove dissolved oxygen. Anhydrous sodium hydrosulfide (NaHS) was 
purchased from Strem Chemicals and handled under nitrogen. DEA NONOate (used to 
generate NO) was purchased from Cayman. Stock solutions of MeRho-Az were prepared 
in an N2-filled glovebox and stored at -25 °C until immediately before use. Aqueous 
stock solutions of L-cysteine, homocysteine, glutathione, NaS2O3, Na2SO3, Na2SO4, and 
H2O2 were freshly prepared in an N2-filled glovebox prior to use. Stock solutions of DEA 
NONOate were prepared in degassed 0.01 M NaOH immediately prior to use. 
Spectroscopic measurements were obtained under anaerobic conditions using septum-
sealed cuvettes obtained from Starna Scientific. 
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General procedure for fluorescence and selectivity measurements. A septum-
sealed cuvette was charged with 3.00 mL of buffer (50 mM PIPES, 100 mM KCl, pH 7.4) 
in a glovebox. After injection of a MeRho-Az (15 µL, 1.0 mM in DMSO) stock solution 
via syringe, an initial fluorescence spectrum was recorded (λex = 476 nm, λem = 480-650 
nm). A NaHS stock solution (15 µL, 50 mM in PIPES buffer) was then injected via 
syringe, and the fluorescence was recorded after 1, 5, 10, 15 30, 45, and 60 minutes. The 
reaction cuvette was incubated at 37 °C during the experiment. 
pKa Determination. An aqueous MeRho solution (20 µM, 100 mM KCl, 10 mL) 
was prepared in a centrifuge tube and acidified to pH 0.656 using 12.1 M HCl. After 
transferring 3.00 mL of this solution to a cuvette, the MeRho fluorescence was recorded 
(λex = 476 nm, λem = 480-650 nm). The solution in the cuvette was then returned to the 
centrifuge tube, and the MeRho solution was basified incrementally to pH 13.859 using 
stock solutions of KOH at various concentrations (10 M, 5 M, 1 M, 0.1 M). A 
fluorescence spectrum was recorded at each pH increment. 
Determination of detection limit. The fluorescence of seven blank cuvettes 
containing MeRho-Az (5 µM, λex = 476 nm, λem = 480-650 nm) was recorded after 
incubation at 37 °C for 90 minutes in PIPES buffer (50 mM, 100 mM KCL, pH 7.4). 
Then MeRho-Az was treated with NaHS at various concentrations (0.10, 2.5, 5.0, 7.5, 15 
µM), and the fluorescence spectra were measured after incubation for 90 min at 37 °C. 
Each data point represents at least three trials. A linear regression curve was constructed 
using the background-corrected fluorescence measurements, and the detection limit was 
determined to be concentration at which the fluorescence equals that of [blank + 3σ]. 
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Cell culture. C6 cells were obtained from ATTC and cultured in Dulbecco’s 
Eagle Medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum (FBS, 
Hyclone) and 1% penicillin/streptomycin. Cells were seeded on a 22 mm diameter glass 
coverslip at ~2.3 x 106 cells per well in a six-well culture dish and allowed to adhere for 
24 h in 2.0 mL DMEM (37 °C, 5% CO2) prior to experiment. Cells were then washed 
with 1x Dulbecco’s Phosphate Buffered Saline (1x DPBS, 3x) and treated with 2.0 mL of 
DMEM containing either 100 nM AP39 or 20 µM AOAA. After incubation for 1 h or 45 
min, respectively, the cells were washed with 1x DPBS (3x) and treated with 2.0 mL of 
DMEM containing 5 µM MeRho-Az and incubated at 37 °C for an additional 45 min. as 
a blank, cells were treated with 5 µM MeRho-Az and incubated in DMEM media for 45 
min. after incubation, cells were washed with 1x DPBS (3x) and fixed in 3.7% 
paraformaldehyde in 1x DPBS at 37 °C for 15 min followed by two rinses and one wash 
with 1x DPBS. Coverslips containing fixed cells were mounted in Vectashield Hardset 
Mounting Medium (Vector Laboratories). 
Fluorescence microscopy and statistical analysis. Images were acquired on a 
confocal microscope (Olympus Fluoview 1000) using oil-immersion 60x (1.4 NA) 
objective. All images were processed with ImageJ software and all statistical comparisons 
were performed using Prism. (One-way ANOVA with Dunnett’s post-test was performed 
using GraphPad Prism version 7.0 for Windows; GraphPad Software: San Diego, CA 
www.graphpad.com) 
Light sheet fluorescence microscopy. Light sheet fluorescence microscopy was 
performed using a home-built instrument similar in design to that of Keller et al.87 and 
described previously.92 In brief: fluorescence excitation illumination was provided by a 
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488 nm Coherent sapphire laser (Coherent, Santa Clara, California), shaped into a thin 
sheet by a mirror galvanometer (Cambridge Technology, Bedford, MA) and telecentric 
scan lens (Sill Optics). Detection was performed with a Zeiss W Plan-Apochromat 
40x/1.0 DIC objective lens and a pco.Edge scientific CMOS camera (PCO, Kelheim, 
Germany). This LSFM setup can image the volume containing the intestinal bulb used in 
this study (400 x 350 x 300 µm3), with 1 µm steps between planes, in approximately 10 
seconds, leading to images un-blurred by gut peristalsis. All microscope control, image 
acquisition, and analysis software were custom-written in MATLAB, C++, and Python. 
Specimen mounting and imaging protocols. Larval zebrafish were mounted for 
imaging as described previously.93 In brief: specimens were held in 0.5% agarose gel, and 
suspended in a temperature controlled specimen chamber containing embryo medium, 
held at 28 °C. All experiments involving zebrafish were performed according to protocols 
approved by the University of Oregon Institutional Animal Care and Use Committee 
(protocol #12-18RR).  
Zebrafish imaging. Larval zebrafish (7 days post fertilization) were orally 
gavaged as described106 with either vehicle (50mM PIPES, pH 7.4), 5 µM MeRho-Az, 5 
µM MeRho-Az + 250 µM DATS + 250 µM GSH, or 5 µM MeRho with a total injection 
volume of 6.9 nL. This injection volume is sufficient to fill the intestinal space. After 60 
minutes of recovery time, a three dimensional image (z spacing of 1 µm) of the intestinal 
bulb of each fish was acquired. Fish in all experimental groups remained alive and 
healthy for the duration of the experiment, with no indication of toxicity for tens of hours 
afterward. Excitation light was provided by a 488 nm laser, delivering 10 mW of power 
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to the sample. Emission light was filtered through a 525/50 nm bandpass filter and 
collected on a sCMOS camera. 
Data Analysis. For each three-dimensional data set, the average background 
intensity was measured in a region of tissue outside of the intestinal tract and used to 
provide a minimum threshold value for pixel intensity. Next, a 20 µM thick section 
within the intestinal bulb was selected at a depth where the bulb was visible in its fullest 
extent. Voxels from these sections with an average voxel intensity greater than the 
background threshold were used to measure the integrated gut brightness. 
Synthesis of 2. Compound 1 (0.400 g, 1.15 mmol) was combined with N-phenyl-
bis(trifluoromethanesulfonamide) (0.412 g, 1.15 mmol), and diisopropylethylamine (0.80 
mL, 4.60 mmol) in DMF (3 mL) and stirred at room temperature for 15 hr. The reaction 
mixture was then diluted with water and extracted into EtOAc. The organic phase was 
washed with brine and dried using Na2SO4. After removal of the solvent under reduced 
pressure, the crude product was purified using column chromatography (100% DCM) to 
afford the pure product 2 as a white crystalline solid (0.550 g, 99% yield). 1H NMR (500 
MHz, CDCl3) δ (ppm): 8.04 (d, J = 7.6 Hz, 1H), 7.66 (m, 2H), 7.24 (d, J = 4.7 Hz, 1H), 
7.16 (d, J = 7.5 Hz, 1H), 6.94 (d, J = 8.8 Hz, 1H), 6.89 (d, J = 8.8 Hz, 1H), 6.79 (s, 1H), 
6.71 (d, J = 8.8 Hz, 1H), 6.65 (d, J = 9.7 Hz, 1H), 3.84 (s, 3H). 13C{1H} NMR (125 MHz, 
CDCl3) δ (ppm): 169.1, 161.8, 152.8, 152.2, 152.2, 135.5, 130.3, 130.2, 129.1, 126.4, 
125.5, 124.0, 120.1, 120.0, 117.5, 116.8, 112.6, 110.7, 110.6, 101.1, 81.8, 55.8. 
Synthesis of MeRho. In a glovebox, compound 2 (0.368 g, 0.769 mmol), 
Pd(OAc)2 (17 mg, 77 µmol), BINAP (72 mg, 120 µmol), and Cs2CO3 (0.752 g, 2.31 
mmol) were dissolved in toluene (20 mL) in a three-neck flask fitted with a reflux 
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condenser. After the reaction vessel was sealed under N2 and removed from the glovebox, 
benzophenone imine was added via syringe (0.152 mL, 0.923 mmol). The reaction was 
heated and stirred at 140 °C for 5 min, and then the temperature was reduced to 100 °C 
for an additional 8 hr. After heating, the reaction mixture was allowed to cool to room 
temperature and was filtered through a plug of celite. After removal of the solvent under 
reduced pressure, the residue was dissolved in a solution of THF (20 mL) and 1 M HCl (2 
mL) and stirred at room temperature overnight. The THF was removed under reduced 
pressure, the crude product was diluted with water, and the pH was neutralized. The 
aqueous solution was extracted into EtOAc, and the organic phase was washed with brine 
and dried using Na2SO4. The crude product was purified using column chromatography 
(hexanes: EtOAc gradient from 1:4 to 4:1) to afford MeRho as a pale orange powder 
(0.226 g, 85% yield). 1H NMR (500 MHz, DMSO) δ (ppm): 7.97 (d, J = 7.7 Hz, 1H), 
7.78 (t, J = 8.0 Hz, 1H), 7.70 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 7.6 Hz, 1H), 6.90 (d, J = 2.5 
Hz, 1H), 6.66 (dd, J = 8.8, 2.5 Hz, 1H), 6.60 (d, J = 8.8 Hz, 1H), 6.44 (d, J = 2.0 Hz, 1H), 
6.37 (d, J = 8.5 Hz, 1H), 6.33 (dd, J = 8.6, 2.0 Hz, 1H), 5.66 (s, 2H), 3.80 (s, 3H). 
13C{1H} NMR (125 MHz, DMSO) δ (ppm): 168.7, 160.9, 152.5, 152.1, 151.9, 151.3, 
135.5, 129.9, 128.8, 128.5, 126.4, 124.5, 124.0, 111.5, 111.3, 111.2, 105.2, 100.7, 99.0, 
83.6, 55.6. HRMS (m/z): [M + H]+ calcd for [C21H16NO4]
+ 346.1079, found 346.1096. 
Synthesis of MeRho-Az. A solution of NaNO2 (31 mg, 0.45 mmol) in water (2.5 
mL) was chilled in an ice bath under foil. A suspension of MeRho (0.100 g, 0.289 mmol) 
in 6 M HCl (2 mL) was added dropwise, and the reaction was stirred at 0 °C for 30 min. 
A solution of NaN3 (58 mg, 0.89 mmol) in water (2 mL) was then added dropwise, and 
the reaction was allowed to warm to room temperature and stir for 4 hr. While taking care 
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to shield the crude material from light, water was added, and the pH was neutralized. The 
crude product was extracted into EtOAc, and the organic phase was washed with brine 
and dried using Na2SO4. Purification of the crude product by preparatory chromatography 
(3:2 hexanes: EtOAc) afforded pure MeRho-Az as a white solid (54 mg, 50% yield). 1H 
NMR (600 MHz, CDCl3) δ (ppm): 8.05 (d, J = 7.6 Hz, 1H), 7.68 (m, 2H), 7.17 (d, J = 7.6 
Hz, 1H), 6.97 (d, J = 2.2 Hz, 1H), 6.80 (m, 2H), 6.73 (m, 2H), 6.65 (dd, J = 8.8, 2.5 Hz, 
1H), 3.87 (s, 3H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm): 169.3, 161.5, 153.0, 152.3, 
152.2, 142.5, 135.1, 129.9, 129.7, 129.1, 126.6, 125.2, 123.8, 115.8, 114.9, 112.0, 110.9, 
107.2, 100.9, 82.4, 55.6. FTIR (ATR, cm-1): 2110 (s), 1761 (s), 1608 (s), 1260 (m), 1495 
(s), 1420 (s), 1282 (m), 1250 (m), 1215 (s), 1161 (m), 1097 (s), 1080 (s), 1030 (m), 828 
(s), 757 (s), 691 (m). HRMS (m/z): [M + H]+ calcd for [C21H14N3O4]
+ 372.0984, found 
372.0975. 
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CHAPTER III 
RATIOMETRIC MEASUREMENT OF HYDROGEN SULFIDE AND 
CYSTEINE/HOMOCYSTEINE RATIOS USING A DUAL-FLUOROPHORE 
FRAGMENTATION STRATEGY 
 
This work includes previously published and coauthored material from Hammers, M. D.; 
Pluth, M. D. Anal. Chem. 2014, 86, 7135-7140. 
 
Introduction 
 Hydrogen sulfide (H2S) has emerged as an integral biological signaling molecule 
since its discovery as the third gasotransmitter.
1-4,108
 Produced endogenously from 
cysteine (Cys), homocysteine (Hcy), and cystathionine, enzymatic H2S biosynthesis 
occurs primarily from cystathionine-β-synthase (CBS) in the brain, cystathionine-γ-lyase 
(CSE) in the liver and kidneys, and 3-mercaptopyruvate sulfurtransferase (3-MST) in 
mitochondria. Once produced, H2S exerts important effects on vasorelaxation, 
inflammation, cell angiogenesis, hippocampal memory formation, and hepatic 
circulation.
1,6-8,10,16,109
 Additionally, abnormal H2S levels are implicated in central 
nervous system diseases such as Down syndrome and Alzheimer’s disease.19,110 
Paralleling these diverse biological roles, basal concentrations of free H2S are dynamic, 
interdependent with biological thiol concentrations, and sensitive to changes in redox 
homeostasis. As substrates in H2S biosynthesis, fluctuations in Cys and Hcy 
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concentrations can dramatically affect the kinetics of H2S generation in enzymatic trans-
sulfuration pathways.
111
 Posttranslational oxidative modification of Cys protein residues 
via S-sulfhydration to form hydrodisulfides (-SSH) is also postulated to be an important 
H2S storage mechanism, which modifies the antioxidant and signal transduction activity 
of H2S.
41,52,112,113
 Deconvoluting cellular H2S generation, translocation, and metabolism 
steps is difficult, however, and chemists have been challenged to develop more accurate 
experimental methodologies for observing these processes. In particular, methods for the 
simultaneous detection and differentiation of H2S and thiols would provide new insight 
into these multifaceted biological interactions. 
 Heightened research interest into the physiological properties of H2S has led to 
the development of small molecule fluorescent probes which are able to more easily 
detect and quantify H2S. Historical techniques for H2S detection including gas 
chromatography, colorimetry, the methylene blue assay, and sulfur-selective electrodes 
all have limitations such as complex workups, slow response rates, and limited 
sensitivity.
22,25-27,114
 One major challenge is differentiating between H2S and thiols due to 
their similar modes of chemical reactivity. Recognizing and exploiting particular 
differences in H2S and thiol reactivity, however, has been a key driver towards 
developing the rapidly emerging suite of small molecule fluorescent probes for H2S. For 
example, although H2S and thiols are both reducing agents, H2S reduces azide and nitro 
groups at a much faster rate than do thiols. Consequently, the selective H2S-mediated 
reduction of azide- and nitro-functionalized fluorophores to elicit a fluorescent response 
has been used as one strategy for H2S detection and imaging.
67-77,79-82,102
 Other strategies, 
including the double-nucleophilic attack of H2S to release or change the photophysical 
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properties of a bound fluorophore
23,57-59,61,63
 and H2S-mediated metal sulfide precipitation 
from fluorophore-ligated metals,
64-66,115-117
 have also been utilized for sulfide detection.  
 Several ratiometric probes have been developed for H2S, which have appealing 
characteristics compared with chemodosimeter probes.
84,118-122
 The magnitude of 
fluorescence response with chemodosimeters is dependent on probe concentration, 
meaning that spatial variations in probe concentration caused by differential probe 
association with components of cellular milieu will reduce the accuracy and reliability of 
these platforms. Reaction-based ratiometric probes help to alleviate the problem of 
differential probe distribution by providing monitorable fluorescence emissions at two 
separate wavelengths, often corresponding to the unreacted probe and its subsequent 
reaction product. The ratio of these two fluorescence signals functions as an inherent self-
calibration, decoupling the observed fluorescence response from probe concentration. A 
desirable extension of this strategy would be to monitor an additional species by 
fluorescence, thus allowing for the ratiometric determination of two different analytes 
simultaneously. To help unravel the intricacies of sulfur redox homoeostasis involving 
H2S and thiol chemistry, a platform that could report on both H2S and thiols 
simultaneously would provide a way to differentiate between their respective 
concentrations, with long term potential applications in diseases in which H2S and thiol 
concentrations are correlated.  
As a proof of concept toward these long term goals, we report herein the 
development and application of a platform for the ratiometric detection of H2S and Cys or 
Hcy based on a dual-fluorophore fragmentation strategy. Supplemental information can 
be found in Appendix B. 
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Results and Discussion 
 Although several ratiometric fluorescent probes for H2S have been reported, there 
are no examples of such constructs that report on the direct measurement of relative H2S 
and thiol concentrations. To address this unmet need, we envisioned a reaction-based 
strategy that takes advantage of the nucleophilicity of H2S and Cys/Hcy to cleave a 
covalent link between two bound fluorophores, nitrobenzofurazan (NBD) and coumarin. 
The key design principle is that reaction with sulfhydryl-containing nucleophiles results 
in fragmentation of NBD and coumarin. We demonstrated previously that H2S and thiols 
readily undergo nucleophilic aromatic substitution (SNAr) with electrophilic NBD 
derivatives to produce NBD-SH and NBD-SR compounds.
123
 Upon reaction with Cys or 
Hcy, both coumarin and NBD-Cys/Hcy are fluorescent, whereas reaction with H2S 
generates coumarin and non-fluorescent NBD-SH. Coumarin functions as an internal 
standard and allows for the ratiometric measurement of NBD-Cys/Hcy vs. NBD-SH, and 
thus the Cys/Hcy to H2S concentration ratios (Scheme 3.1).  
If each reaction product after reaction with H2S or Cys/Hcy provides distinct 
spectral features, we hypothesized that each could be monitored independently and used 
to determine relative concentrations of H2S and Cys/Hcy in mixed-analyte environments. 
Although NBD-SH and NBD-SR are both non-fluorescent, NBD-adducts of Cys and Hcy 
undergo subsequent intermolecular rearrangement with adjacent amine functionalities to 
form fluorescent amino-bound NBD-NHR compounds (Scheme 3.2a, b).
124-126
 The 
coumarin fluorophore appended to the NBD scaffold through an ether linkage provides 
an additional fluorescent reporter that is liberated upon any nucleophilic substitution. 
Based on this design, coumarin fluorescence is directly proportional to the combined H2S 
37 
 
and Cys/Hcy concentrations in solution upon fragmentation of the probe, whereas the 
NBD component is proportional to the Cys/Hcy concentration exclusively, given that 
NBD-SH is non-fluorescent. Conveniently, the ratiometric probe NBD-Coum was 
prepared with good yield in one step from commercially available 4-chloro-7-
nitrobenzofurazan (NBD-Cl) and 4-methylumbelliferone (coumarin) in DMF, using NEt3 
as a base (Scheme 3.2c).  
 
 
Scheme 3.1. General strategy employed in this work for generating a ratiometric 
response to H2S and Cys/Hcy levels. 
 
To evaluate the suitability of our design strategy and NBD-Coum as a platform 
for ratiometric determination of H2S and Cys/Hcy levels, we first examined its reactivity 
with sulfhydryl-containing nucleophiles by UV-vis spectroscopy. Treatment of NBD-
Coum (5 µM) with 50 equiv. of NaHS, a common H2S source, in PIPES buffer (50 mM, 
100 mM KCl, pH 7.4) resulted in the rapid disappearance of NBD-Coum absorbance at 
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380 nm (< 1 min) with concomitant appearance of two absorbances at 322 nm and 535 
nm, corresponding to coumarin and NBD-SH respectively. These results confirm that 
reaction of NBD-Coum with H2S results in nearly instantaneous probe fragmentation into 
coumarin and NBD components. Treatment of NBD-Coum with either Cys or Hcy 
resulted in new absorbances centered at 475 nm, consistent with formation of amino-
bound NBD.
127 
By contrast, reaction of NBD-Coum with either glutathione (GSH) or N-
acetylcysteine (NAC), two thiols lacking the proximal amines required to undergo the 
intramolecular rearrangement, generated an absorbance at 425 nm, consistent with 
formation of NBD-SR adducts (Figure 3.1). 
 
 
Scheme 3.2. a) The differential reactivity of NBD-Coum with H2S and Cys/Hcy allows 
for the ratio of H2S and Cys/Hcy in a sample to be determined, b) Non-fluorescent S-
bound NBD-Cys/Hcy undergoes an intramolecular rearrangement to form the fluorescent 
N-bound adducts, c) Synthesis of NBD-Coum. 
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Figure 3.1. Comparison of the UV-vis spectra of NBD-Coum (5 µM, black) and the HS-, 
RHN-, and RS-bound NBD products from reactions with 50 equiv. of NaHS (250 µM, 
green), Cys or Hcy (250 µM, blue), and GSH or NAC (250 µM, red) in PIPES buffer (50 
mM, 100 mM KCl, pH 7.4) after incubation for 15 minutes at 25 °C. 
 
 We next examined the reactivity of NBD-Coum with H2S and Cys/Hcy by 
fluorescence spectroscopy to determine whether differentiable fluorescent products are 
produced in each case. In its unreacted state, NBD-Coum is non-fluorescent due to self-
quenching of the bound coumarin and NBD fluorophores. Treatment of NBD-Coum with 
50 equiv. of NaHS resulted in ejection of the coumarin fluorophore and generation of a 
strong emission band centered at 449 nm. As established previously, NBD-SH is non-
fluorescent due to the high acidity of the sulfhydryl proton and consequent deprotonation 
at pH 7.4.
123
 By contrast to the reactivity observed with NaHS, reaction of NBD-Coum 
with Cys or Hcy generated two fluorescent products corresponding to coumarin and the 
N-bound Cys/Hcy NBD adducts. Consecutive excitations at 322 nm and 475 nm resulted 
in two discrete fluorescence signals centered at 449 nm and 549 nm corresponding to 
coumarin and NBD-Cys/Hcy, respectively. These results are again consistent with the 
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dual-fluorophore fragmentation design, liberating coumarin upon reaction of NBD-Coum 
with either H2S or Cys/Hcy, providing an internal standard for ratiometric differentiation. 
The resulting NBD product, however, is non-fluorescent from reaction with H2S and 
fluorescent with Cys/Hcy reaction. The 100 nm separation between coumarin and NBD-
Cys/Hcy fluorescence maxima allows for unambiguous measurement of each signal. 
 To further validate our design strategy, we next investigated the dynamic range of 
the system by treating NBD-Coum (5 µM) with mixed Cys:H2S solutions with 
stoichiometries ranging from 1:75 to 75:1, while keeping the total sulfur concentration 
constant in all samples (50 equiv.). Under these experimental conditions, the two terminal 
data points represent 3 µM:247 µM in Cys:H2S and H2S:Cys, respectively; however, 
lower analyte detection limits should be accessible using lower probe and/or analyte 
concentrations. In each experiment, the fluorescence intensities at 449 nm (coumarin) and 
549 nm (NBD-Cys) were measured. When excited at their respective λmax values, 
coumarin has >15-fold stronger fluorescence than NBD-Cys. To set the two baseline 
fluorescence intensities at the same order of magnitude, coumarin was excited at 400 
nm.As the [Cys]/[H2S] ratio increases, more NBD-Cys is formed relative to NBD-SH, 
thus generating a stronger fluorescent signal at 549 nm. Consistent with our design 
hypothesis, the F549/F449 ratio increased accordingly with higher [Cys]/[H2S]. 
Furthermore, measurement of the ratio of the fluorescence intensities from coumarin and 
NBD-Cys generated a sigmoidal response (R
2
 = 0.997), which allows for the ratiometric 
determination of relative H2S and Cys concentrations with a dynamic range of nearly four 
orders of magnitude (Figure 3.2). 
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Figure 3.2. Ratiometric response (F549/F449) of NBD-Coum to varying Cys:H2S 
stoichiometries (75:1, 20:1, 5:1, 2.5:1, 1:1, 1:2.5, 1:5, 1:20, and 1:75). Inset: Resultant 
fluorescence spectra from varying Cys:H2S ratios. Normalized coumarin fluorescence 
(λex = 400 nm, λem = 449 nm) remains constant while NBD-Cys fluorescence (λex = 475 
nm, λem = 549 nm) increases with [Cys]/[H2S]. Conditions: 5 µM NBD-Coum, 250 µM 
combined NaHS + Cys, PIPES buffer (50 mM, 100 mM KCl, pH 7.4). Data were 
acquired after 15 minute incubation at 25 °C. Each data point represents the average of 
three trials. Error bars were calculated as standard error. 
  
Having demonstrated the efficacy of the NBD-Coum platform in detecting 
different H2S:Cys ratios, we next investigated the selectivity of probe for H2S and 
Cys/Hcy over other biologically relevant nucleophiles and reactive sulfur, oxygen, and 
nitrogen species (RSONs). NBD-Coum (5 µM) was treated with 10 equiv. of 
nucleophilic amino acids (Ser, Tyr, Lys, and Thr), oxidizing agents (H2O2), sulfur anions 
(SO3
2–
, SO4
2–
, and S2O3
2–
), and reactive nitrogen species (NO and HNO). In all cases, 
incubation for 15 minutes resulted in a negligible fluorescence response at both 449 nm 
and 549 nm (Figure 3.3). Treatment of NBD-Coum with GSH released the coumarin 
fluorophore and generated S-bound NBD-GSH, which was essentially non-fluorescent, 
and no turn-on at 549 nm was observed. Although high levels of GSH would likely 
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interfere with the ability of NBD-Coum to effectively differentiate H2S and Cys/Hcy in 
many live-cell experiments, studies in blood plasma may still be accessible due to much 
lower concentrations of free GSH. Oxygen and nitrogen nucleophiles were insufficiently 
nucleophilic at physiological pH to react with NBD-Coum, which indicates that 
fragmentation of NBD-Coum into its respective NBD and coumarin components requires 
SNAr by stronger sulfhydryl-containing nucleophiles. Taken together, these selectivity 
studies highlight the selectivity of the NBD-Coum scaffold for differentiating between 
H2S and Cys/Hcy.  
 
 
Figure 3.3. Selectivity profile of NBD-Coum toward nucleophilic amino acids and 
reactive sulfur, oxygen, and nitrogen species. From left to right: blank, NaHS, L-cysteine, 
DL-homocysteine, glutathione, L-serine, L-tyrosine, L-lysine, L-threonine, H2O2, 
Na2SO3, Na2SO4, Na2S2O3, DEA NONOate, and Angeli’s salt. Conditions: 5 µM NBD-
Coum, 50 µM RSONs, PIPES buffer (50 mM, 100 mM KCl, pH 7.4), λex/λem = 400 
nm/449 nm and 475 nm/549. Data were acquired after 15 minute incubation at 25 °C. 
 
Sulfur pools of H2S and sulfhydryl-containing amino acids and peptides respond 
continuously to various levels of oxidative stress in biological systems by undergoing 
changes in their redox states. To simulate such changes, we investigated whether NBD-
Coum could detect changes in oxidative stress levels in a simulated sulfur pool consisting 
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of H2S (125 µM), Cys (125 µM), and cystine (250 µM) (Figure 3.4). All experiments 
were compared to a control case in which the sulfur species were combined in an N2-
purged cuvette. To enhance oxidizing conditions, the sample was bubbled with either air 
or O2, or alternatively treated with NaOCl. Treatment of the sample with tris(2-
carboxyethyl)phosphine (TCEP), a common reductant used to reduce disulfides, was used 
to mimic reductive conditions. In all cases of induced oxidative stress, the relative ratio of 
Cys/H2S decreased, which is consistent with Cys oxidation. By contrast, under reductive 
conditions, the ratio of Cys/H2S increased, which is consistent with TCEP-mediated 
reduction of cystine to Cys. Taken together, these results demonstrate that NBD-Coum is 
able to effectively monitor changes in redox state in the sulfur pool. 
 
 
Figure 3.4. Response of the sulfur pool containing H2S, Cys, and cystine to oxidative and 
reductive influences. Relative Cys:H2S ratios decrease under oxidative conditions and 
increase under reducing conditions. Conditions: The initial sulfur pool (125 µM H2S, 125 
µM Cys, 250 µM cystine) was incubated in PIPES buffer (50 mM, 100 mM KCl, pH 7.4) 
for 60 minutes at 25 °C under each redox condition and treated with 5 µM NBD-Coum. 
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Conclusion and Bridge 
 We have demonstrated the design and application of a platform to effectively 
measure H2S and Cys/Hcy ratios using a dual-fluorophore fragmentation strategy. The 
mechanism of action relies not only on the differences in reactivity of H2S and Cys/Hcy 
to provide differentiable reaction products with NBD-Coum, but also in their similarity as 
potent nucleophiles capable of undergoing SNAr with the electrophilic scaffold. The 
strategy described here introduces a new class of compounds that could offer insights into 
thiol-H2S dynamics such as redox homeostasis or enzymatic metabolism. 
 In addition to developing new strategies for the detection of H2S, developing new 
methods and compounds that controllably deliver H2S into biological systems is an 
important field of study. Toward this goal, we developed the synthesis of an amine-
functionalized dithiolethione-based H2S donor, which we functionalized with non-
steroidal anti-inflammatory drugs. These drug conjugates are hydrolytically stable, 
offering an improved alternative to ester-functionalized conjugates which are 
hydrolytically unstable. This strategy will be described in its entirety in Chapter IV. 
 
Experimental 
Materials and Methods. Reagents were purchased from Sigma-Aldrich or Tokyo 
Chemical Industry (TCI) and used as received. Deuterated solvents were purchased from 
Cambridge Isotope Laboratories and used as received. Silica gel (SiliaFlash F60, 
Silicycle, 230 - 400 mesh) was used for column chromatography. 1H and 13C{1H} NMR 
spectra were recorded on a Varian INOVA 500 MHz NMR instrument. Chemical shifts 
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are reported in ppm relative to residual protic solvent resonances. UV–visible spectra 
were acquired on a Cary 100 spectrometer equipped with a Quantum Northwest TLC-42 
dual cuvette temperature controller at 25.00 ± 0.05 °C. Fluorescence spectra were 
obtained on a Quanta Master 40 spectrofluorometer (Photon Technology International) 
equipped with a Quantum Northwest TLC-50 temperature controller at 25.0 ± 0.05 °C.  
Spectroscopic Materials and Methods. Piperazine-N,N′-bis(2-ethanesulfonic acid) 
(PIPES, Aldrich) and potassium chloride (99.999%, Aldrich) were used to make buffered 
solutions (50 mM PIPES, 100 mM KCl, pH 7.4) in Millipore water. Anhydrous sodium 
hydrosulfide (NaHS) was purchased from Strem Chemicals and handled under nitrogen. 
Angeli’s salt and DEA NONOate were purchased from Cayman and used to generate 
HNO and NO, respectively. Stock solutions of NBD-Coum in DMSO were prepared in 
an N2-filled glovebox and stored at -25 °C until immediately prior to use. Stock solutions 
of L-cysteine, homocysteine, glutathione, serine, lysine, threonine, H2O2, Na2SO3, 
Na2SO4, and Na2S2O3 in buffer, and tyrosine in 0.1 M NaOH were freshly prepared in a 
glovebox. Stock solutions of NaHS in degassed buffer, and Angeli’s salt and DEA 
NONOate in degassed 0.01 M NaOH, and L-cystine in degassed 1 M HCl were prepared 
under nitrogen immediately prior to use. All absorption and fluorescence measurements 
were made under anaerobic conditions, and cuvette solutions were prepared under an 
inert atmosphere in septum-sealed cuvettes obtained from Starna Scientific. 
General Procedure for Fluorescence and Selectivity Measurements. A cuvette 
containing 3.0 mL of PIPES buffer (50 mM, 100 mM KCl, pH 7.4) and a septum cap was 
prepared in a glovebox. An NBD-Coum stock solution (15 µL, 1.0 mM) was added via 
syringe to the cuvette, and initial fluorescence spectra were recorded with 
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excitation/emission at 400/405-600 nm and 475/485-650 nm. After addition of a NaHS 
stock solution (15 µL, 50 mM) via syringe and incubation for 15 minutes at 25 °C, 
fluorescence scans were again recorded. For selectivity and ratiometric experiments, the 
emission maxima at 449 nm and 549 nm were compared. 
General Procedure for the Ratiometric Detection of H2S and Cysteine. Stock 
solutions of NaHS (15 µL, 100 mM) and cysteine (15 µL, 100 mM) were combined and 
diluted with PIPES buffer (50 mM, 100 mM KCl, pH 7.4, 30 µL) to prepare a second 
stock solution containing 50 mM total sulfur content at a desired 1:1 H2S:Cys ratio. The 
fluorescence response of NBD-Coum was measured upon treatment with this second 
solution following the general procedure described above. The H2S:Cys stoichiometry in 
each experiment was controlled by varying the isolated H2S or Cys stock solution 
volumes used to prepare secondary stock solutions accordingly at the desired ratio.  
Procedure for Redox Comparisons. A stock solution of L-cystine was prepared (25 
mM) in 1 M HCl. Preliminary stock solutions of NaHS (15 µL, 100 mM) and cysteine 
(15 µL, 100 mM) were combined and diluted with PIPES buffer (50 mM, 100 mM KCl, 
pH 7.4, 30 µL) to prepare a second stock solution containing equimolar concentrations of 
NaSH and Cys (25 mM). A cuvette containing 3.0 mL of PIPES buffer (50 mM, 100 mM 
KCl, pH 7.4) and a septum cap was prepared under ambient atmosphere and purged with 
N2, air, or O2 for 15 minutes. The cuvette was then charged with the NaHS/Cys (15 µL) 
and cystine (15 µL) stock solutions and incubated for 60 minutes at 25 °C to allow for 
equilibration of the sulfur pool. The cuvette was then injected with a NBD-Coum stock 
solution (15 µL, 1.0 mM), incubated an additional 15 minutes, and the fluorescence 
response of NBD-Coum at 449 nm and 549 nm was recorded. For the redox comparisons 
47 
 
with NaOCl or TCEP, a cuvette containing 3.0 mL of PIPES buffer (50 mM, 100 mM 
KCl, pH 7.4) and a septum cap was prepared under ambient atmosphere. The cuvette was 
then charged with stock solutions of TCEP or NaOCl (15 µL, 50 mM), NaHS/Cys, and 
cystine and incubated for 60 minutes at 25 °C. The cuvette was injected with a NBD-
Coum stock solution, incubated for 15 minutes, and the fluorescence response of NBD-
Coum was measured. 
Synthesis of NBD-Coum. A solution of 4-chloro-7-nitrobenzofurazan (60 mg, 0.32 
mmol), 4-methylumbelliferone (42 mg, 0.24 mmol), and triethylamine (42 µL, 0.32 
mmol) in DMF was stirred at room temperature for one hour. The reaction mixture was 
then diluted with water and extracted into EtOAc. The organic phase was washed with 
brine and dried over Na2SO4 to yield the crude product. Purification via column 
chromatography (hex:EtOAc gradient) afforded NBD-Coum as a pure orange solid (72 
mg, 88%). 1H NMR (500 MHz, DMSO) δ (ppm): 8.67 (d, J = 8.3 Hz, 1H), 7.98 (d, J = 
8.7 Hz, 1H), 7.56 (d, J = 2.4 Hz, 1H), 7.44 (dd, J = 8.7, 2.4 Hz, 1H), 7.00 (d, J = 8.3 Hz, 
1H), 6.46 (s, 1H), 2.48 (s, 3H). 13C{1H} NMR (125 MHz, DMSO) δ (ppm): 159.9, 156.1, 
154.7, 153.4, 152.3, 145.9, 144.9, 135.6, 131.7, 128.3, 118.6, 117.2, 114.5, 112.3, 110.0, 
18.7. HRMS (m/z): [M + H]+ calcd for [C16H10N3O6]
+ 340.0565, found 340.0570. 
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CHAPTER IV 
SYNTHESIS OF AMINO-ADT PROVIDES ACCESS TO HYDROLYTICALLY-
STABLE AMIDE-COUPLED HYDROGEN SULFIDE-RELEASING DRUG 
TARGETS 
 
This work includes previously published and coauthored material from Hammers, M. D.; 
Singh, L.; Montoya, L. A.; Moghaddam, A. D.; Pluth, M. D. Synlett 2016, eFirst online. 
[DOI: 10.1055/s-0035-1560603]. 
 
Introduction 
 Hydrogen sulfide (H2S) has joined carbon monoxide (CO) and nitric oxide (NO) 
as the third endogenously produced gaseous signaling molecule, or gasotransmitter.
112
 
Biosynthesized through enzymatic and non-enzymatic pathways, cellular H2S regulates 
critical cardiovascular, immune, nervous, respiratory, and gastrointestinal system 
functions and is implicated in a number of diseases.
4
 In addition to central nervous 
system diseases such as Down syndrome,
19 Alzheimer’s,128 and Parkinson’s disease,129 
the role of H2S in inflammation and angiogenesis has been of particular interest.
12,130
 
Different studies have shown H2S to exhibit either anti-inflammatory or pro-
inflammatory effects depending on which model is being examined. For example, H2S-
mediated activation of KATP channels limits leukocyte adherence to vascular endothelium 
and reduces edema formation in rats, both anti-inflammatory effects.
131 
In models of 
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septic shock, however, inflammatory responses are observed in conjunction with elevated 
levels of H2S,
132,133
 and inhibition of enzymatic H2S production during endotoxemia 
mitigates both inflammation and organ injury.
134
 Furthermore, enhanced levels of KATP 
activation have been linked with LPS-induced models of hypotension and 
hyporeactivity.
135
 These observations suggest that the interactions of H2S with KATP 
channels during inflammation may be circumstantially either beneficial or deleterious. In 
addition to inflammation, signaling actions of H2S have significant effects on 
angiogenesis. H2S promotes endothelial cell growth through upregulation of vascular 
endothelial growth factor (VEGF) expression,
136 
and topical H2S administration to burn 
wounds has been shown to stimulate wound healing on rats.
137 
More recently, H2S 
treatment was shown to enhance angiogenesis after ischemic stroke though cooperation 
of astrocytes and endothelial cells.
138
 Taken together, these broad-reaching roles of H2S 
highlight the pharmacological potential of exogenously administered H2S. 
 Although a variety of H2S delivery methods exist, conflicting results are often 
observed depending upon which H2S donor is used,
12
 and developing new types of 
synthetic H2S-donating compounds is an active area of investigation.
42,139
 By contrast to 
the more commonly utilized inorganic sulfide sources such as Na2S and NaHS, which 
deliver an immediate burst of H2S into an experimental system, small-molecule donors 
are designed to more closely resemble continuous, endogenous H2S release. One of the 
most extensively studied H2S donors is 5-(4-hydroxyphenyl)-3H-1,2-dithiol-3-thione 
(ADT-OH), which contains the H2S-releasing dithiolethione moiety. This phenolic 
compound is easily functionalized via ester linkages (Scheme 4.1), and indeed a number 
of ester-bound ADT derivatives of nonsteroidal anti-inflammatory (NSAIDs) and other 
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drugs are being investigated for their synergistic anti-inflammatory and antioxidant 
potential. For example, an ADT-functionalized diclofenac derivative, S-diclofenac, not 
only exhibited greater anti-inflammatory effects than the parent diclofenac in LPS-
injected rats, but also displayed reduced gastrointestinal toxicity.
140
 Other demonstrations 
of ester-functionalized ADT drugs include derivatives of naproxen,
45
 valproic acid,
141 
aspirin,
44
 sildenafil,
142
 and mesalamine.
143
 One practical challenge associated with 
implementing these ADT derivatives in drug delivery, however, is the potential for 
hydrolysis of the ester bond linking the two drug components. A recent report 
demonstrated that hydrolysis of polymeric ester-bound ADT in phosphate buffered saline 
occurred with a half-life of approximately 30 minutes.
144 
Therefore, stomach acid would 
likely catalyze hydrolysis and component fragmentation, which would be particularly 
problematic in oral drug delivery systems. One logical solution to this unwanted 
hydrolysis is to link ADT to the drugs through amide, rather than ester, bonds.{Xie, 2014 
#2}  
 
 
Scheme 4.1. Esterification of ADT-OH to form H2S-releasing drugs. 
 
 To better enable access to more robust ADT-functionalized NSAIDs, we report 
here a straightforward synthesis and purification of 5-(4-aminophenyl)-3H-1,2-dithiol-3-
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thione (amino-ADT, ADT-NH2) and compare the hydrolytic stability between amide- and 
ester-coupled ADT. We also provide conditions for coupling of ADT-NH2 with common 
drugs, including naproxen and valproic acid and demonstrate cytotoxicities for the ester- 
and amide-linked versions of these drug conjugates. Supplemental information can be 
found in Appendix C. 
 
Results and Discussion 
 To access ADT-NH2, direct conversion of the phenolic group in ADT-OH to an 
amine would be preferred. Our attempts using a reported one-pot SNAr-Smiles 
rearrangement strategy (Scheme 4.2A)
145
 or palladium-catalyzed Buchwald-Hartwig 
amination of triflated ADT (Scheme 4.2B) were unsuccessful. We reasoned that the 
presence of highly metalophilic sulfur atoms in the dithiolethione moiety, combined with 
the sulfophilicity of Pd, makes Pd-catalyzed cross-couplings with ADT problematic. 
Therefore, we reasoned that ADT-NH2 would need to be constructed from an aniline 
precursor and that any metal-mediated steps must be incorporated prior to installation of 
the dithiolethione moiety (Scheme 4.2C). 
Fortunately, organotrifluoroborate salts have emerged as excellent substrates for 
Suzuki-Miyaura reactions due to their improved air-stability and reduced cost.
146,147
 In 
particular for our purposes, they offer an attractive alternative to expensive vinyl boronic 
acid and boronate substrates.
148,149
 Utilizing this strategy, we found that ADT-NH2 is 
accessible in two steps from commercially available starting materials with 56% overall 
yield (Scheme 4.3A). Palladium-catalyzed coupling of 4-chloro-(N-Boc)aniline with 
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potassium trans-1-propenyltrifluoroborate installs a propenyl dithiolethione precursor 
onto the protected aniline to form compound 1. Subsequent reaction with elemental sulfur 
at 180 °C both forms the dithiolethione and deprotects the aniline to give ADT-NH2.
 
We 
note that although the synthesis of ADT-NH2 is suggested in U.S. Patent 2007/0197479 
A1, August 23, 2007, the precursor to compound 1 in the patent application is not a 
known compound, and no preparation is presented.
 
Methylated ADT-NMe2 (Scheme 
4.3D) was synthesized according to the same scheme using 4-bromo-N,N-dimethylaniline 
as starting. ADT-OH and ADT-OMe were synthesized using previously-reported 
methods,
140
 and we report an updated purification method in the Supporting Information. 
Importantly, dithiolethione formation from reaction of elemental sulfur with an aryl 
propenyl group appears to be general, as similar reaction conditions may be used to form 
ADT-NH2, ADT-NMe2, and ADT-OMe from their respective propenyl starting materials. 
 
 
Scheme 4.2. Potential synthetic routes to ADT-NH2. 
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Scheme 4.3. Synthesis of ADT-containing compounds including a) ADT-NH2, b) ADT-
OAc and ADT-NAC, c) ADT drug conjugates, and d) ADT-NMe2 and ADT-OMe.
 
 
 
Having developed a facile route to access ADT-NH2, our next objective was to 
demonstrate effective functionalization of the amine. Acetamide (ADT-NAc) and acetate 
(ADT-OAc) ADT derivatives were synthesized as model compounds for hydrolysis 
study, both through reactions with acetyl chloride (Scheme 4.3B). Ester- and amide-
coupled ADT derivatives of naproxen and valproic acid (ADT-ORox, ADT-OVal, ADT-
NRox, and ADT-NVal) were coupled using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC·HCl) and catalytic 4-dimethylaminopyridine 
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(DMAP) as coupling agents (Scheme 4.3C). Both ADT-NH2 and ADT-OH are weak 
nucleophiles, making substitution reactions challenging. The dithiolethione group is 
inductively electron-withdrawing, as reflected by the increased acidity of ADT-OH 
compared with phenol (pKa of 7.86 vs. 10.00), slightly more so than a nitrile group (pKa 
of 4-cyanophenol is 7.95).
150 
Resonance contributions from lone-pair electron 
delocalization produce partial zwitterionic character in these compounds, which further 
decreases their nucleophilicities (Scheme C.1). We found that ADT-NH2 is less reactive 
than ADT-OH, which suggests a higher degree of electron delocalization. For example, 
esterification of ADT to form esters ADT-ORox and ADT-OVal proceed at room 
temperature, whereas 120 °C temperatures are required for the corresponding amide 
couplings of ADT-NRox and ADT-NVal. Nonetheless, ADT-NH2 is readily linked 
through amide bonds using these standard methodologies, which can likely be extended 
toward coupling with other carboxylic acid-containing NSAIDs. 
 To compare the hydrolytic stability of ester- and amide-bound ADT derivatives in 
an acidic environment akin to the stomach, the hydrolysis of model compounds ADT-
OAc and ADT-NAc was investigated in 0.10 M HCl using UV-vis spectroscopy and 
HPLC. After addition of ADT-OAc (20 µM) to a cuvette containing 0.10 M HCl, a 
decrease in absorption at 320 nm was observed with concomitant growth of a new peak at 
358 nm, which is consistent with formation of ADT-OH after ester hydrolysis (Figure 
4.1A). By contrast, treatment of ADT-NAc (20 µM) resulted in only minimal hydrolysis 
to form ADT-NH2 (λmax= 311 nm) (Figure 4.1B). Over the course of the 18-hour 
experiment, 69% of the ester-bound ADT was hydrolyzed, whereas only 9% of the amide 
was hydrolyzed under identical conditions (Figure 4.1C). ADT-OH and ADT-NH2 
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fragments were also identified as reaction byproducts using HPLC analysis. (Figure C.1). 
As expected, these results clearly demonstrate the enhanced chemical stability of amide 
linkages toward hydrolysis in ADT derivatives by contrast to ester linkages. 
 
 
Figure 4.1. Hydrolysis of acyl ADT derivatives (20 µM) in 0.10 M HCl at 37 °C, a) UV-
vis timecourse of ADT-OAc (blue = initial, black = final) over 18 hours overlaid with the 
absorbance spectrum of ADT-OH (red), b) Time course of ADT-NAc (blue = initial, 
black = final) over 18 hours overlaid with the absorbance spectrum of ADT-NH2 (red), c) 
Calculated percent hydrolysis of ADT-OAc and ADT-NAc. 
 
 Undesired fragmentation of ADT-functionalized drugs may have toxicological 
consequences in addition to in vivo decomposition. To probe these properties, the effect 
of ADT functionalization on cytotoxicity was tested in HeLa cells using the MTT 
assay.
151
 Cells were treated with ADT derivatives at 31, 55, 95, 170, 290, 510, and 900 
µM to observe the effect of each derivative on cell proliferation. Free ADT-OH and 
ADT-NH2 exhibited similar levels of toxicity (Figure 4.2A), whereas alkylated 
derivatives ADT-OMe and ADT-NMe2 were considerably more toxic (Figure 4.2.B). At 
concentrations below 290 µM, naproxen (ADT-ORox, ADT-NRox, Figure 4.2C) and 
valproic acid (ADT-OVal, ADT-NVal, Figure 4.2D) derivatives all exhibited lower 
toxicity than the free ADT species. While amide and ester ADT derivatives generally had 
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similar toxicity profiles, ADT-ORox exhibited the highest level of toxicity among them. 
All eight derivatives had considerable toxicity at concentrations approaching 1 mM.  
 
 
Figure 4.2. MTT cell proliferation assay of ADT derivatives (31-900 µM) in HeLa cells. 
Cells were treated with a) ADT-OH or ADT-NH2 (black), b) ADT-OMe or ADT-NMe2 
(red), c) ADT-ORox or ADT-NRox (green), d) ADT-OVal or ADT-NVal (blue) for 24 
hours. 
 
Previous experiments using the MTT assay have suggested that free ADT-OH and 
ADT-OMe are more cytotoxic than ester- or ether-functionalized ADT.
24
 The authors 
attributed this toxicity to possible direct interactions of ADT with intracellular enzymes 
and organelles. Our results are consistent with those findings (Figure 4.2), where ADT-
OH and ADT-NH2 were both more toxic than either ester- or amide-functionalized ADT. 
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Methylation further increased the toxicity of the free ADTs. Naproxen has been shown to 
have anti-proliferative properties in HeLa and osteosarcoma cells,
152,153
 which may 
contribute to our observed enhanced toxicity of ADT-ORox vs. ADT-NRox in the event 
of intracellular ADT-ORox hydrolysis. This trend was not observed with valproic acid 
derivatives, and correspondingly, valproic acid was previously shown to have minimal 
toxicity in glioma or neuroblastoma cells below 1 mM.
154,155
  
 
Conclusion and Bridge 
Amide-coupled ADT derivatives help provide a solution to challenges associated 
with undesired acid-catalyzed hydrolysis of ester-bound ADT-NSAIDs in oral drug 
delivery applications. By utilizing advances in Suzuki-Miyaura cross-coupling using 
trifluoroborate salts, we successfully accessed the key intermediate 1 toward our target 
H2S donor, ADT-NH2. We hope that the proof of concept syntheses of ADT-NVal and 
ADT-NRox will assist future investigations toward unlocking the therapeutic potential of 
H2S-releasing drugs. 
In addition to dithiolethione-based H2S-releasing compounds, polysulfide-
containing molecules are also known to release H2S. To understand the chemical 
reactivity of these compounds, we investigated the H2S-releasing capabilities of a library 
of tetrasulfide derivatives with the goal of creating a toolbox of controllable donors for 
use in biological studies. This strategy will be described in its entirety in Chapter V. 
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Experimental 
Materials and methods. Reagents were purchased from Sigma-Aldrich or 
Tokyo Chemical Industry (TCI) and used as received. ADT-OH, ADT-OMe, and 
ADT-OVal were synthesized as reported previously with modifications as 
described below.{Li, 2007 #114;Isenberg, 2007 #23} Deuterated solvents were 
purchased from Cambridge Isotope Laboratories and used as received. Silica gel 
(SiliaFlash F60, Silicycle, 230 - 400 mesh) was used for column chromatography. 
Preparatory chromatography was performed on Silicycle SiliaPlates (1 mm 
thickness). 
1
H and 
13
C
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 NMR spectra were recorded on a Varian INOVA 500 
MHz NMR instrument. Chemical shifts are reported in ppm relative to residual 
protic solvent resonances. UV–visible spectra were acquired on a Cary 100 
spectrometer equipped with a Quantum Northwest TLC-42 dual cuvette 
temperature controller at 37.00 ± 0.05 °C. HPLC samples were analyzed using 
reverse-phase HPLC (Akta purifier; Amersham Biosciences) on a C18 column 
(Hypersil GOLD, 5 mm 4.6/250 mm; Thermo Scientific).  
Spectroscopic materials and methods. Stock solutions of ADT-OH, ADT-
OMe, ADT-OVal, ADT-ORox, ADT-NVal, and ADT-NRox were prepared in an 
N2-filled glovebox and stored at -25 °C until immediately before use. 
Spectroscopic measurements were obtained using septum-sealed cuvettes obtained 
from Starna Scientific. 
MTT Assay
151
 of ADT Derivatives. C6 cells were seeded at 2,500 cells per 
well on a 96 well plate the night before drug treatment to allow for adherence of 
the cells to the bottom of the wells. The following day, cells were treated with 
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ADT derivatives (31, 55, 95, 170, 290, 510, and 900 µM) for 24 hours at 37 °C 
and 5% CO2. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide) was dissolved in PBS at 5 mg/mL and filtered to sterilize and remove 
any insoluble residue present. The MTT solution (10 µL) was added to all wells 
and was incubated at 37 °C for 3.5 hours. The solution was removed and 100 µL 
of acidic isopropanol (0.04 M HCl, 0.01% IGEPAL in isopropanol) was added to 
all wells and placed on a shaker for 15 minutes in the dark at room temperature. 
After incubation, the plate was read on a Tecan Safire2 UV-vis plate reader at 570 
nm. 
Synthesis of 5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione(ADT-OMe). 
Anethole (4.15 g, 28.0 mmol) and sulfur (6.00 g, 187 mmol) were dissolved in DMF (25 
mL) and refluxed at 170 °C under N2 for 8 hours. After the reaction flask was cooled to 
room temperature, the reaction mixture was diluted into water and extracted into toluene. 
The toluene fractions were dried with Na2SO4 and concentrated, and the remaining solid 
was recrystallized from 5% methanol/DCM. These crystals were then further purified by 
column chromatography (4:1 Hex:EtOAc) to give pure product as a brownish-red 
crystalline solid (2.27 g, 34% yield).
 1H NMR (500 MHz, DMSO) δ (ppm): 7.87 (d, J = 
8.8 Hz, 2H), 7.75 (s, 1H), 7.07 (d, J = 8.8 Hz, 2H), 3.84 (s, 3H). 
13
C{
1
H} NMR (125 
MHz, DMSO) δ (ppm): 214.70, 173.77, 162.66, 134.11, 128.98, 123.64, 115.02, 55.63.  
Synthesis of 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADT-OH). 
ADT-OMe (2.00 g, 8.32 mmol), and anhydrous pyridine hydrochloride (5.77 g, 
49.9 mmol) were added to an oven-dried pressure vessel under N2. The apparatus 
was submerged into an oil bath and stirred at 220 °C. After stirring for 25 minutes, 
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the reaction flask was cooled to room temperature, and the contents were dissolved 
in methanol and transferred to a round bottom flask. The methanol was removed, 
and the contents of the round bottom were dissolved in a 50:50 mixture of 0.5 M 
HCl and EtOAc in order to solubilize the crude product. This mixture was then 
further diluted with water and extracted into EtOAc. The organic layer was dried 
with Na2SO4 and purified by column chromatography (3:2 Hex:EtOAc) to afford 
ADT-OH as a lovely golden orange solid (1.60 g, 85%). 
1
H NMR (500 MHz, 
DMSO) δ (ppm): 10.49 (s, 1H), 7.78 (d, J = 7.8 Hz, 2H), 7.69 (s, 1H), 6.89 (d, J = 
7.8 Hz, 2H). 
13
C{
1
H} NMR (125 MHz, DMSO) δ (ppm): 214.38, 174.39, 161.75, 
133.45, 129.19, 122.13, 116.42.  
Synthesis of (E)-tert-Butyl (4-(prop-1-en-1-yl)phenyl)carbamate (1). In 
a glovebox, 4-chloro-(N-Boc)aniline (350 mg, 1.54 mmol), potassium trans-1-
propenyltrifluoroborate (273 mg, 1.85 mmol), Pd(OAc)2 (35 mg, 0.16 mmol), 
RuPhos (144 mg, 0.308 mmol), and Cs2CO3 (1.5 g, 4.6 mmol) were added to an 
oven-dried 3-neck round bottom flask fitted with a reflux condenser. The sealed 
apparatus was removed from the glovebox, and a degassed solvent mixture of 4:1 
THF:water (10 mL) was added via syringe; minimal solvent aids with full 
conversion and overall yield. The reaction mixture was stirred at 80 °C under N2 
for 14 hrs, after which the solvent was removed by rotary evaporation. The residue 
was dissolved in EtOAc and filtered through celite. The filtrate was washed with 
water, brine, and dried with Na2SO4. The crude product was purified using column 
chromatography (20-50% Hex:EtOAc gradient) and further purified by 
recrystallization from hexanes to afford the pure product as a light brown solid 
61 
 
(318 mg, 88% yield). 
1H NMR (500 MHz, DMSO) δ (ppm): 9.31 (s, 1H), 7.38 (d, 
J = 8.5 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H), 6.31 (dd, J = 15.8, 1.43 Hz, 1H), 6.11-
6.18 (m, 1H), 1.81 (dd, J = 6.56, 1.5 Hz, 3H), 1.47 (s, 9H). 
13
C{
1
H} NMR (125 
MHz, DMSO) δ (ppm): 152.67, 138.26, 131.34, 130.41, 125.94, 123.34, 118.08, 
78.95, 28.11, 18.19. HRMS [M + Na]
+ 
calcd for [NaC14H19NO2]
+
 256.1313; found, 
256.1309.  
Synthesis of 5-(4-Aminophenyl)-3H-1,2-dithiole-3-thione (ADT-NH2). 
Compound 1 (100 mg, 0.429 mmol) and sulfur (96 mg, 3.0 mmol) were added to 
an oven-dried pressure vessel and dissolved in DMAc (6 mL) under N2, and the 
reaction was stirred at 180 °C for 18 hours. After stirring, the solvent was removed 
under vacuum whilst heated at 40 °C. The crude residue was diluted with water, 
extracted into EtOAc. The combined organic fractions were washed with brine and 
dried with Na2SO4. The compound was purified using column chromatography 
(3% MeOH:DCM) to afford the pure product as a dark brown solid (66 mg, 68% 
yield). 
1
H NMR (500 MHz, CD2Cl2) δ (ppm): 7.51 (d, J = 8.7 Hz, 2H), 7.36 (s, 
1H), 6.71 (d, J = 8.7 Hz, 2H), 4.27 (br, 2H). 
13
C{
1
H} NMR (125 MHz, CD2Cl2) δ 
(ppm): 215.05, 174.86, 151.60, 133.66, 129.25, 121.63, 115.29. HRMS [M + H]
+ 
calcd for [C9H8NS3]
+
 225.9819; found, 225.9823. 
Synthesis of (E)-N,N-Dimethyl-4-(prop-1-en-1-yl)aniline (N,N-Dimethyl 
propenylaniline). In a glovebox, 4-bromo-N,N-dimethylaniline (250 mg, 1.25 
mmol), potassium trans-1-propenyltrifluoroborate (222 mg, 1.50 mmol), Pd(OAc)2 
(14 mg, 0.062 mmol), RuPhos (58 mg, 0.12 mmol), and Cs2CO3 (1.22 g, 3.75 
mmol) were added to an oven-dried 3-neck round bottom flask fitted with a reflux 
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condenser. The sealed apparatus was removed from the box, and a degassed 
solvent mixture of 4:1 THF:water (10 mL) was added via syringe. The mixture 
was stirred at 80 °C under N2 for 12 hrs, after which the solvent was removed by 
rotary evaporation. The residue was dissolved in EtOAc and filtered through celite. 
The filtrate was washed with water, brine, and dried with Na2SO4. The compound 
was purified using column chromatography (20-50% Hex:EtOAc gradient) to 
afford the pure product as a brown solid (163 mg, 81% yield). 
1
H NMR (500 MHz, 
CD2Cl2) δ (ppm): 7.20 (d, J = 8.7 Hz, 2H), 6.66 (d, J = 8.8 Hz, 2H), 6.31 (d, J = 
17.1 Hz, 1H), 5.96-6.08 (m 1H), 2.92 (s, 6H), 1.84 (d, J = 8.8 Hz, 3H). 
13
C{
1
H} 
NMR (125 MHz, CD2Cl2) δ (ppm): 150.17. 131.07, 126.93, 121.53, 112.86, 40.76, 
30.15, 18.57. 
Synthesis of 5-(4-(Dimethylamino)phenyl)-3H-1,2-dithiole-3-thione 
(ADT-NMe2). N,N-dimethyl propenylaniline (163 mg, 1.01 mmol) and sulfur (227 
mg, 7.08 mmol) were added to an oven-dried pressure vessel and dissolved in 
DMAc (6 mL) under N2, and the reaction was stirred at 180 °C for 18 hours. After 
stirring, the solvent was removed under vacuum whilst heated at 40 °C. The crude 
residue was dissolved in EtOAc and washed with water, brine, and dried with 
Na2SO4. The compound was purified using column chromatography (1% 
MeOH:DCM) to afford the pure product as a brown solid (150 mg, 59% yield).
 1
H 
NMR (500 MHz, CD2Cl2) δ (ppm): 7.58 (d, J = 8.8 Hz, 2H), 7.37 (s, 1H), 6.7 (d, J 
= 8.8 Hz, 2H), 3.06 (s, 6H). 
13
C{
1
H} NMR (125 MHz, CD2Cl2) δ (ppm): 214.23, 
175.22, 153.72, 132.72, 128.98, 119.11, 112.30, 40.44. HRMS [M]
+ 
calcd for 
[C11H11NS3]
+
 253.0053; found, 253.0046. 
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Synthesis of 4-(3-Thioxo-3H-1,2-dithiol-5-yl)phenyl acetate (ADT-
OAc). ADT-OH (50 mg, 0.22 mmol), acetyl chloride (17 mg, 0.22 mmol), and 
triethylamine (67 mg, 0.66 mmol) were dissolved in dry THF (2 mL) and stirred at 
room temperature under N2. After 22 hours the solvent was removed by rotary 
evaporation, and the residue was purified by preparative chromatography (3:2 
Hex:EtOAc) (16 mg, 22% yield).
 1
H NMR (500 MHz, CD2Cl2) δ (ppm): 7.72 (d, J 
= 8.6 Hz, 2H), 7.42 (s, 1H), 7.25 (d, J = 8.6 Hz, 2H), 2.31 (s, 3H). 
13
C{
1
H} NMR 
(125 MHz, CD2Cl2) δ (ppm): 216.21, 172.56, 169.38, 154.28, 136.61, 129.75, 
128.79, 123.50, 21.48. HRMS [M]
+ 
calcd for [C11H8O2S3]
+
 267.9686; found, 
267.9694. 
Synthesis of N-(4-(3-Thioxo-3H-1,2-dithiol-5-yl)phenyl)acetamide 
(ADT-NAc). ADT-NH2 (50 mg, 0.22 mmol), acetyl chloride (17 mg, 0.22 mmol), 
and triethylamine (67 mg, 0.66 mmol) were dissolved in dry THF (2 mL) and 
stirred at room temperature under N2. After 22 hours the solvent was removed by 
rotary evaporation, and the residue was purified by preparative chromatography 
(3:1 Hex:EtOAc) (11 mg, 19% yield).
 1
H NMR (500 MHz, (CD3)2CO) δ (ppm): 
9.53 (br, 1H), 7.85 (m, 4H), 7.56 (s, 1H), 2.13 (s, 3H). 
13
C{
1
H} NMR (125 MHz, 
(CD3)2CO) δ (ppm): 216.54, 174.12, 169.47, 144.35, 135.41, 128.80, 126.97, 
120.22, 24.43. HRMS [M]
+ 
calcd for [C11H8NOS3]
+
 266.9846; found, 266.9843. 
Synthesis of (S)-4-(3-Thioxo-3H-1,2-dithiol-5-yl)phenyl 2-(6-
methoxynaphthalen-2-yl)propanoate (ADT-ORox). Naproxen (50 mg, 0.22 
mmol), ADT-OH (49 mg, 0.22 mmol), EDC·HCl (42 mg, 0.22 mmol), and 4-
dimethylaminopyridine (3 mg, 0.03 mmol) were dissolved in dry THF (4 mL) and 
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stirred at room temperature under N2 for 24 hours. After stirring, the solvent was 
removed under vacuum. The crude residue was dissolved in EtOAc and washed 
with water, brine, and dried with Na2SO4. The crude product was purified via 
preparative TLC (3:2 Hex:EtOAc) to afford the pure product as a dark red solid 
(14 mg, 15% yield).
 1
H NMR (500 MHz, CD2Cl2) δ (ppm): 7.75-7.79 (m, 3H), 
7.77 (m, 2H), 7.50 (dd, J= 8.4, 1.9 Hz, 1H), 7.39 (s, 1H), 7.14-7.17 (m, 4H), 4.11-
4.16 (q, J = 7.2 Hz, 1H), 3.92 (s, 1H), 1.69 (d, J = 7.2 Hz, 3H). 
13
C{
1
H} NMR (125 
MHz, CD2Cl2) δ (ppm): 216.18, 173.21, 172.52, 158.48, 154.44, 136.60, 135.38, 
134.50, 129.77, 129.52, 128.75, 127.95, 126.70, 126.61, 123.30, 119.70, 110.57, 
106.13, 55.87, 46.12, 18.75. HRMS [M + H]
+ 
calcd for [C23H19O3S3]
+ 
439.0496; 
found, 439.0476. 
Synthesis of 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-propylpentanoate 
(ADT-OVal). Valproic acid (32 mg, 0.22 mmol), ADT-OH (52 mg, 0.22 mmol), 
EDC·HCl (44 mg, 0.22 mmol), and 4-dimethylaminopyridine (2 mg, 0.02 mmol) 
were dissolved in dry THF (4 mL) and stirred at room temperature under N2 for 24 
hours. After stirring, the solvent was removed under vacuum. The crude residue 
was dissolved in EtOAc and washed with water, brine, and dried with Na2SO4. The 
crude product was purified via preparative TLC (3:2 Hex:EtOAc) to afford the 
pure product as a dark red solid (52 mg, 67% yield). 
1
H NMR (500 MHz, CD2Cl2) 
δ (ppm): 7.72 (d, J = 8.8 Hz, 2H), 7.43 (s, 1H), 7.22 (d, J = 8.8 Hz, 2H), 2.61-2.67 
(m, 1H), 1.71-1.78 (m, 2H), 1.55-1.62 (m, 2H), 1.40-1.48 (m, 4H), 0.97 (t, J = 7.3 
Hz, 6H). 
13
C{
1
H} NMR (125 MHz, CD2Cl2) δ (ppm): 216.03, 174.80, 172.46, 
154.32, 136.42, 129.49, 128.61, 123.38, 45.74, 34.91, 21.09, 14.19. 
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Synthesis of (S)-2-(6-methoxynaphthalen-2-yl)-N-(4-(3-thioxo-3H-1,2-
dithiol-5-yl)phenyl)propanamide (ADT-NRox). In a glovebox, naproxen (24 
mg, 0.10 mmol), ADT-NH2 (26 mg, 0.12 mmol), EDC·HCl (20 mg, 0.10 mmol), 
and 4-dimethylaminopyridine (2 mg, 0.02 mmol) were added to an oven-dried 
pressure vessel and dissolved in dry CHCl3 (4 mL) under N2, and the reaction was 
stirred at 120 °C for 27 hours. After stirring, the reaction mixture was diluted with 
DCM and washed with 0.1 M HCl, 0.5 M K2CO3, and brine. The organic layer was 
dried with Na2SO4, and purified by preparative TLC (1:1 Hex:EtOAc) to afford the 
pure product as a dark red solid (9 mg, 18% yield).
 1
H NMR (500 MHz, CD2Cl2) δ 
(ppm): 7.74-7.78 (m, 3H), 7.59 (m, 4H), 7.44 (dd, J = 8.5, 1.8 Hz, 1H), 7.38 (br, 
1H), 7.37 (s, 1H), 7.15-7.18 (m, 2H), 3.91 (s, 3H), 3.88 (q, J = 7.1 Hz, 1H), 1.64 
(d, J = 7.1 Hz, 3H). 
13
C{
1
H} NMR (125 MHz, CD2Cl2) δ (ppm): 215.84, 173.18, 
173.10, 158.54, 142.42, 136.22, 135.62, 134.56, 129.73, 129.58, 128.37, 128.32, 
127.43, 126.90, 126.55, 120.31, 119.83, 106.19, 55.88, 48.73, 18.93. HRMS [M + 
H]
+ 
calcd for [C23H19NO2S3]
+ 
438.0656; found, 438.0645. 
Synthesis of 2-Propyl-N-(4-(3-thioxo-3H-1,2-dithiol-5-
yl)phenyl)pentanamide (ADT-NVal). In a glovebox, ADT-NH2 (200 mg, 0.888 
mmol), 2-propylpentanoic acid (192 µL, 1.20 mmol), EDC·HCl (230 mg, 1.20 
mmol), and 4-dimethylaminopyridine (15 mg, 0.12 mmol) were added to an oven-
dried pressure vessel and dissolved in dry CHCl3 (8 mL) under N2, and the reaction 
stirred at 120 °C for 2.5 days. The reaction mixture was diluted with DCM and 
washed with 0.1 M HCl, 0.5 M K2CO3, and brine. The organic layer was dried 
with Na2SO4 and purified via column chromatography (20-50% Hex:EtOAc 
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gradient). Pure product was obtained as an orange-red solid (170 mg, 54% yield).
 
1
H NMR (500 MHz, CD2Cl2) δ (ppm): 7.71 (d, J = 8.8 Hz, 2H), 7.66 (d, J= 8.8 Hz, 
2H), 7.42 (s, 1H), 7.39 (br, 1H), 2.24 (m, 1H), 1.63-1.70 (m, 2H), 1.45-1.52 (m, 
2H), 1.32-1.39 (m, 4H), 0.92 (t, J = 7.3 Hz, 6H). 
13
C{
1
H} NMR (125 MHz, 
CD2Cl2) δ (ppm): 215.90, 175.26, 173.28, 142.48, 135.65, 128.42, 127.41, 120.44, 
49.37, 35.76, 21.37, 14.48. HRMS [M]
+ 
calcd for [C17H21NOS3]
+
 351.0785; found, 
351.0773. 
Hydrolysis of ADT-OAc and ADT-NAc. A cuvette was charged with 3.00 
mL of 0.10 M HCl. After addition of an ADT-OAc or ADT-NAc stock solution 
(60 µL, 1.0 M in DMSO) via syringe, a UV-vis spectrum was recorded at 0, 60, 
120, 240, 540, and 1080 minutes. Each reaction cuvette was incubated at 37 °C 
during the course of the experiment. Percent hydrolysis values were calculated 
relative to ADT-OH or ADT-NH2 absorbances (20 µM in 0.10 M HCl) at 358 or 
311 nm, respectively. 
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CHAPTER V 
FUNCTIONALIZED TETRASULFIDES AS EASILY ACCESSABLE HYDROGEN 
SULFIDE DONORS 
 
This work includes unpublished material and involved contributions from Mary S. Earp 
and Michael D. Pluth. I was the primary researcher and composer of the writing. 
 
Introduction 
 Hydrogen sulfide (H2S) is the latest gaseous molecule to be classified as a 
gasotransmitter because of its importance in cell signaling.
112
 Enzymatically produced 
H2S regulates physiological function in the immune, nervous, cardiovascular, endocrine, 
and gastrointestinal systems.
4
 Many of these signaling processes proceed through S-
sulfhydration of protein cysteines,
52
 interplay with reactive oxygen and nitrogen species 
such as nitric oxide (NO),
156
 or interactions with heme-containing proteins.
157
 The broad-
ranging implications of H2S activity in the body have stimulated interest in administering 
exogenous H2S in therapeutic applications. For example, the role of H2S in inflammation 
has been well documented, although consistent findings have been elusive.
12-15,158,159
 H2S 
can act with either anti- or pro-inflammatory effects, and the variability in observed 
results depends on the specific experimental conditions and mode of H2S delivery used. 
In particular, inorganic sulfide sources such as NaHS and synthetic donors usually give 
markedly different, and often conflicting, results due to contrasting H2S release kinetics.
12
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Taken together, judicious selection of H2S donor appears essential to eliciting a desired 
physiological response. 
 To diversify the suite of available H2S donor alternatives for both research and 
therapeutic applications, a variety of synthetic donors have been developed (Figure 
5.1a).
42,43
 For example, H2S-releasing dithiolethiones like ADT-OH and ADT-NH2 have 
been functionalized with non-steroidal anti-inflammatory drugs (NSAIDs) through acyl 
linkages and were studied for their synergistic antioxidant and anti-inflammatory 
properties.
44,45,140-143
 Although these compounds are easily functionalized, ADT-OH is 
expensive ($5/mg), and ADT-NH2 is not yet commercially available. Furthermore, the 
mechanism of H2S extrusion from dithiolethiones in biological milieu remains unclear. 
GYY4137, another common H2S donor, was initially prepared as a more water soluble 
derivative of Lawesson’s reagent.160 GYY4137 releases H2S through hydrolysis, and this 
donor motif has been used extensively in cancer and cardiovascular disease research.
47
 
Unlike ADT-OH, the mechanism of sulfide release from GYY4137 is well-defined and 
proceeds by slow hydrolysis of its phosphinodithioate functional group in a pH-
dependent fashion to release H2S. This release, however, is inefficient at physiological 
pH (< 10% release observed over 7 days).
161
 Protected N-mercaptobenzamides release 
H2S after thiol activation through a perthiol intermediate.
162
 An extension of the strategy 
included caged perthiols, which exhibited protective effects in a model of myocardial 
ischemia-reperfusion injury.
163
 Geminal dithiols, another caged H2S source, were shown 
to release sulfide after photoactivation.
164
 Finally, one naturally-occurring source of H2S 
is allyl polysulfides such as diallyl di- and trisulfide (DADS and DATS, respectively), 
which is found in garlic and is recognized as contributing many of the health benefits of 
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garlic. These release H2S in the presence of thiols through a cascade of nucleophilic 
substitutions and thiol/disulfide exchanges.
105,165
 
 
 
Figure 5.1. a) Examples of established H2S donor scaffolds, b) Proposed thiol/disulfide 
exchange cascade which results in H2S release from tetrasulfide donors. 
 
Inspired by the abundance of polysulfide-containing compounds in nature which 
release H2S,
139
 we have investigated symmetric tetrasulfide derivatives as an easily 
accessible sulfane sulfur source for H2S donation (Figure 5.1b). We hypothesized that 
tetrasulfides would release H2S in a similar manner to DATS, and also that such 
molecules could be easily accessed through simple synthetic methods, thus increasing the 
diversity of molecules available for different studies. We demonstrate herein the ease and 
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versatility of tetrasulfide synthesis using commercially available sulfur monochloride 
(S2Cl2) and study the kinetics of H2S release both as a function of thiol concentration and 
of tetrasulfide derivatization. Supplemental information can be found in Appendix D. 
 
Results and Discussion 
 Chemists have created a number of molecular scaffolds for H2S delivery in 
biological systems. The structures of donors such as ADT-OH/NH2 and GYY4137, 
however, are not easily modified to customize H2S release rates. Our goal was to develop 
an accessible, adaptable, and inexpensive strategy for generating H2S using 
functionalized polysulfides. We forged our initial hypothesis based on H2S release from 
trisulfide-containing DATS. We reasoned that if thiol-mediated H2S extrusion from 
trisulfides is general and extendable to a range of functionalized polysulfides, then the 
scaffold could become modular and broadly functionalized to achieve controllable H2S 
release.  
First we investigated the viability of polysulfide-based H2S donor syntheses. 
Symmetric trisulfides are most easily prepared from substitution reactions of sulfur 
dichloride (SCl2) with two equiv. of thiol;
166
 however, SCl2 is not commercially available 
at high purities and must be prepared from the reaction of hazardous chlorine gas and 
elemental sulfur or S2Cl2.
167
 Alternatively, thiols react cleanly with S2Cl2 to form 
tetrasulfides,
168
 and S2Cl2 is not only more stable and easier to work than SCl2, it is 
commercially available at synthetically-viable purities. Therefore, we chose 
functionalized tetrasulfides as our target H2S donors. We found that dropwise addition of 
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a S2Cl2 solution into a thiol-containing reaction solution in anhydrous solvents and under 
N2, followed by aqueous workup, afforded alkyl tetrasulfides of N-acetylcysteine (NAC) 
and fully protected N-acetylcysteine methyl ester (Table 5.1, entries 1 and 2). Reactions 
to form aryl tetrasulfides bearing both electron-withdrawing and -donating groups (3-7) 
were all well tolerated, and most products were obtained as analytically pure compounds, 
but can also be purified by recrystallization if necessary. These results demonstrate the 
versatility of tetrasulfide syntheses from inexpensive and accessible starting materials.  
 
  
Table 5.1. Synthesis of functionalized tetrasulfides.  
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With a library of functionalized tetrasulfides in hand, we then characterized the 
thiol-dependence of H2S release from N-acetylcysteine tetrasulfide ((NAC)2S4) as a 
model tetrasulfide using an H2S-selective electrode. No H2S was observed over 15 
minutes after injection of (NAC)2S4 (10 µM) into aqueous buffer (pH 7.4 PBS, 1 mM 
CTAB) (Figure D.1), which indicates that water is insufficiently nucleophilic to cleave 
tetrasulfide S-S bonds. Upon injection of glutathione (GSH), a short induction period 
with no observed H2S was followed by a significant increase in signal as (NAC)2S4 
released H2S (Figure 5.2a). The rate of H2S evolution increased dramatically with higher 
concentrations of GSH with a linear dependence according to [GSH] (Figure 5.2b). 
Minimal H2S was observed with equimolar amounts of GSH and (NAC)2S4, and no H2S 
was observed when [GSH] < [(NAC)2S4]. This observation supports the requirement of 
more than one equiv. of thiol in order to liberate H2S from polysulfides.  
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Figure 5.2. a) Thiol-concentration dependence of H2S release from (NAC)2S4 (10 µM) 
after treatment with 1.0, 10, 50, 100, 250, 500, and 1000 µM GSH over 90 minutes in 
PBS buffer (pH 7.4, 1 mM CTAB), b) Linear relationship between [GSH] and rate of H2S 
release. Rates were calculated as initial rates after induction period. 
 
To better understand the mechanism of H2S release from tetrasulfides, we 
investigated release rates from p-functionalized aryl tetrasulfides. Initially, we expected 
electron-withdrawn aryl tetrasulfides to react more quickly than electron-rich 
tetrasulfides. Surprisingly, very little difference in H2S release rate was observed after 
treatment of tetrasulfides (10 µM) containing electron-donating (–N(CH3)2, –OCH3, –
CH3) and -withdrawing (–F, –NO2) groups with 10 equiv. GSH (Table 5.2, Figure D.2). 
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Alkyl derivatives ((NAC)2S4, (PCys)2S4), however, reacted one order of magnitude more 
slowly than the aryl tetrasulfides. Curiously, reaction of the most electron-withdrawn aryl 
tetrasulfide (–NO2) with GSH was the slowest, with the kinetic profile closely resembling 
those of (NAC)2S4 and (PCys)2S4 (vida infra). 
 
p-Substituent Initial Rate (nA*min
-1
) 
–N(CH3)2 2.9 
–OCH3 2.5 
–CH3 2.4 
–FAr 2.4 
–NO2 0.27 
(NAC)2S4 0.13 
(PCys)2S4 0.24 
 
Table 5.2. Rate of H2S release from functionalized tetrasulfides (10 µM) after addition of 
GSH (100 µM) in PBS buffer (pH 7.4, 1 mM CTAB). Rates were calculated as initial 
rates after induction period. 
 
We propose the following mechanistic details supported by these data. Although 
H2S release from diallyl polysulfides may involve nucleophilic attack at either the sulfur 
atoms or the allylic α-carbon,105 tetrasulfides lacking an allylic position will facilitate 
attack predominantly at sulfur only. An incoming GSH nucleophile has two distinct 
pathways with which to initiate reaction with a tetrasulfide: either attack at an interior 
sulfur atom or at an exterior sulfur atom along the tetrasulfide chain. Internal attack on a 
symmetric R-S4-R tetrasulfide includes a non-productive pathway in which the reaction 
products are a new thiol, R-SH, and G-S4-R tetrasulfide (Figure 5.3a). G-S4-R is unable 
to release H2S directly and must react with another thiol to move closer to H2S release. 
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Only an internal attack producing R-S3-G and a terminal R-SSH perthiol pushes the 
tetrasulfide closer toward H2S release. Reaction of R-SSH with another equivalent of 
thiol produces H2S. Inclusion of this non-productive pathway works to effectively 
decrease the overall rate of H2S release from tetrasulfides involving nucleophilic attack at 
an interior sulfur atom. Alternatively, nucleophilic attack at an exterior sulfur will only 
result in R-SS-G disulfide and R-SSSH persulfide as reaction products (Figure 5.3b), 
where R-SSSH may directly undergo further reactivity to give H2S.  
Our data suggest that an exterior sulfur bound to the sp
2
 carbon of an aryl ring is 
sufficiently electron-deficient to steer toward external attack, which results in a 
significantly faster overall release of H2S for aryl tetrasulfides. It is not altogether clear 
why modifying the electronics within the aryl substituent does not elicit a stronger effect 
on the H2S release rate. Perhaps the rate-determining, H2S-releasing step from R-SSSH is 
far enough removed that the process is electronically isolated. By contrast, alkyl 
tetrasulfides such as our cysteine derivatives undergo nucleophilic attack preferentially 
on the interior of the tetrasulfide chain and are thus slowed considerably in their H2S 
release. In the case of the nitro-functionalized aryl tetrasulfide, resonance stabilization of 
p-nitrothiophenol anion causes GSH to react with two rapid interior attacks to give 2 R-
SH and G-S4-G, which then reacts in a similar fashion as (NAC)2S4 and (PCys)2S4. UV-
vis data is consistent with this hypothesis. We observed the appearance of p-
nitrothiophenol more rapidly than H2S release (Figure D.3). Taken together, these 
mechanistic insights help dictate the design principles for selecting tetrasulfide H2S 
donors to match a desired H2S-release rate profile.  
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Figure 5.3. a) Interior attack of an incoming GSH nucleophile on the tetrasulfide may 
result in a non-productive pathway, which slows down the overall rate of reaction, b) 
Exterior attack leads directly to H2S-releasing perthiol compounds and gives H2S more 
quickly. 
 
Conclusion 
 Emulating polysulfide-containing compounds found in nature, we’ve shown that 
symmetrically-functionalized tetrasulfides represent a straightforward avenue for 
delivering H2S. The modular synthesis of these donors offers customizability and makes 
possible the production of a wide range of donors both quickly and inexpensively, which 
is a significant improvement upon previously-developed synthetic H2S donors. By 
exploiting the two different modes of observed reactivity, users can easily explore the 
effect of variable H2S release rates on physiological processes in biological experiments. 
Because NAC has long been used to protect against oxidative stress,
169
 (NAC)2S4 may 
provide health benefits from synergistic H2S and NAC activities. Furthermore, aryl-
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tethered tetrasulfides also have application in prodrug-release strategies. Our lab 
continues to study the mechanism of H2S release from these and other synthetic donors. 
 
Experimental 
Materials and methods. Reagents were purchased from Sigma-Aldrich or 
Tokyo Chemical Industry (TCI) and used as received. S2Cl2 was purchased from 
Sigma-Aldrich (98% purity). Deuterated solvents were purchased from Cambridge 
Isotope Laboratories and used as received. Silica gel (SiliaFlash F60, Silicycle, 
230 - 400 mesh) was used for column chromatography. Preparatory 
chromatography was performed on Silicycle SiliaPlates (1 mm thickness). 
1
H and 
13
C{
1
H} NMR spectra were recorded on a Varian INOVA 500 MHz NMR 
instrument. Chemical shifts are reported in ppm relative to residual protic solvent 
resonances. UV–visible spectra were acquired on a Cary 100 spectrometer 
equipped with a Quantum Northwest TLC-42 dual cuvette temperature controller 
at room temperature. H2S-release data were acquired using a World Precision 
Instruments (WPI) ISO-H2S-2 sensor connected to a TBR Free Radical Analyer. 
Spectroscopic materials and methods. Phosphate buffered saline tablets 
(EMD Millipore) and cetyltrimethylammonium bromide (CTAB) were used to 
prepare buffered solutions (10 mM phosphate buffer, 140 mM NaCl, 3 mM KCl, 1 
mM CTAB, pH 7.4) in Millipore water. Stock solutions of tetrasulfides (10 mM) 
and GSH (10 mM, 50 mM, 100 mM) were prepared in DMSO and buffer, 
respectively, in an N2-filled glovebox and stored at -25 °C until immediately 
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before use. All electrode experiments were performed using previously degassed 
buffer, however reaction vessels were briefly exposed to ambient atmosphere 
during experimental setup. 
General procedure for H2S-release experiments. A scintillation vial containing 
20.0 mL of PBS buffer (10 mM phosphate buffer, 140 mM NaCl, 3 mM KCl, 1 mM 
CTAB, pH 7.4) with stir bar was prepared in a glovebox. The electrode was inserted into 
the buffered solution, and the signal current was allowed to equilibrate. A (NAC)2S4 stock 
solution (20 µL, 10.0 mM) was added via syringe to the vial, and the signal current was 
again allowed to equilibrate. After addition of a GSH stock solution (20 µL, 50 mM) via 
syringe, the signal current was recorded over 90 minutes. 
General procedure for alkyl tetrasulfide synthesis. A reaction solution of aryl thiol 
(1.00 mmol) in THF (10 mL) was prepared under N2 at room temperature. To this 
solution was added an anaerobic solution of S2Cl2 (0.040 mL, 0.495 mmol) in THF (1 
mL) dropwise. The reaction was allowed to stir overnight and diluted with THF. After 
addition of brine and extraction with THF, the organic phases were combined and dried 
using Na2SO4. The solvent was removed under reduced pressure to afford the desired 
tetrasulfide as pure compound. 
General procedure for aryl tetrasulfide synthesis. A reaction solution of aryl thiol 
(1.00 mmol) in diethyl ether (10 mL) was prepared under N2 at room temperature. To this 
solution was added an anaerobic solution of S2Cl2 (0.495 mmol) in diethyl ether (1 mL) 
dropwise. The reaction was allowed to stir overnight and diluted with diethyl ether. After 
addition of water and extraction with ether, the organic phases were combined and dried 
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using Na2SO4. The solvent was removed under reduced pressure to afford the desired 
tetrasulfide as pure compound. 
3,3'-Tetrasulfanediylbis(2-acetamidopropanoic acid) ((NAC)2S4, 1). Yield = 80%. 
Product was recovered as a pure yellowish-white solid. 1H NMR (500 MHz, DMSO) δ 
(ppm): 12.96 (s, 2H), 8.36 (d, J = 7.9 Hz, 2H), 4.55 (td, J = 8.4, 4.7 Hz, 2H), 3.46-3.07 
(m, 4H), 1.86 (s, 6H). 13C{1H} NMR (125 MHz, DMSO) δ (ppm): 171.63, 169.38, 54.90, 
51.31, 22.37. HRMS [M+Na]+ calcd for [NaC10H16N2O6S4]
+ 410.9789; found, 410.9771. 
Dimethyl 3,3'-tetrasulfanediylbis(2-acetamidopropanoate) ((PCys)2S4, 2). Yield = 
77%. Product was recovered as a yellowish-white solid. 1H NMR (500 MHz, DMSO) δ 
(ppm): 8.49 (d, J = 7.8 Hz, 2H), 4.63 (td, J = 8.3, 5.0 Hz, 2H), 3.66 (s, 6H), 3.42-3.25 (m, 
4H), 3.46-3.07 (m, 4H), 1.86 (s, 6H). 13C{1H} NMR (125 MHz, DMSO) δ (ppm): 
170.69, 169.48, 52.27, 51.29, 51.14, 22.28. 
4,4'-Tetrasulfanediylbis(N,N-dimethylaniline) (3). Yield = 67%. Product was 
recovered as a yellow solid. 1H NMR (500 MHz, CDCl3) δ (ppm): 7.73 (d, J = 8.4 Hz, 
4H), 7.56 (d, J = 8.7 Hz, 4H), 3.20 (s, 12H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm): 
142.52, 138.71, 130.38, 121.81, 46.42. 
1,4-Bis(4-methoxyphenyl)tetrasulfane (4). Yield = 78%. Product was recovered as a 
yellow oil. 1H NMR (500 MHz, CDCl3) δ (ppm): 7.51 (d, J = 8.9 Hz, 4H), 6.86 (d, J = 8.9 
Hz, 4H), 3.82 (s, 6H). 
1,4-Di-p-tolyltetrasulfane (5). Yield = 100%. Product was recovered as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.46 (d, J = 8.1 Hz, 4H), 7.14 (d, J = 8.0 Hz, 4H), 
2.36 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm): 139.01, 132.99, 131.21, 130.05, 
21.36. 
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1,4-Bis(4-fluorophenyl)tetrasulfane (6). Yield = 64%. Product was recovered as a 
yellow oil. 1H NMR (500 MHz, CDCl3) δ (ppm): 7.53 (dd, J = 8.9, 5.2 Hz, 4H), 7.03 (t, J 
= 8.7 Hz, 4H).  
1,4-Bis(4-nitrophenyl)tetrasulfane (7). Yield = 78%. Product was recovered as a 
yellow solid. 1H NMR (500 MHz, CDCl3) δ (ppm): 8.20 (d, J = 8.9 Hz, 4H), 7.62 (d, J = 
8.9 Hz, 4H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm): 147.12, 144.19, 126.53, 124.59. 
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CHAPTER VI 
CONCLUDING REMARKS 
 
In recent years, the scientific community has invested substantial intellectual 
resources in studying physiological H2S, and we’ve made great strides toward 
understanding what this important gasotransmitter does in the human body. A main 
driver of this progress has been the rapid development of H2S-selective fluorescent 
probes and the live-cell/in vivo experiments that they facilitate. The enhanced 
fluorescence response demonstrated herein with MeRho-Az with respect to other azide 
reduction-based scaffolds (>10-fold improvement) represents another leap forward. 
MeRho-Az has sufficient sensitivity for cell and whole-animal studies, and we expect 
that others will build upon our pioneering work with zebrafish larvae and light sheet 
fluorescence microscopy to investigate sulfide dynamics in other organisms. The 
ratiometric dual-fluorophore fragmentation strategy with NBD-Coum also provides 
insight into H2S-thiol interactions, which are important in redox balance, sulfide 
biosynthesis and storage, and protein-thiol activity modifications. As we more clearly 
define the question of “what does physiological H2S do?,” fluorescent probes and 
strategies such as these will be useful in also defining exactly “how does H2S elicit these 
physiological effects?” One last important question is, “can we effectively utilize what 
we know about physiological H2S in disease treatments?” Dithiolethione-NSAID 
conjugates are promising, and coupling of the H2S-releasing and anti-inflammation 
components through stable amide linkages will help ensure that the spatial relationship 
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between the two remains intact after oral drug ingestion. Finally, the simplicity of 
functionalized tetrasulfides as H2S donors makes them very versatile and customizable. 
(NAC)2S4 is expected to have very low cytotoxicity and is a good candidate for drug 
screening. Taken together, the chemical tools and strategies developed in this work are 
facilitators of effective research and experimentation. We continue to work with our 
collaborators using these compounds to push forward the boundaries of what we know 
about H2S in human biology. 
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APPENDIX A 
CHAPTER II SUPPLEMENTARY INFORMATION AND SPECTRA 
 
Supplementary Figures 
 
Figure A.1. Normalized absorption (solid line) and emission (dashed line) spectra of 
MeRho. Conditions: 5 µM MeRho, PIPES buffer (50 mM, 100 mM KCl, pH 7.4), λex = 
476 nm. 
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Figure A.2. a) Integrated fluorescein (20 µM, λex = 494 nm, λem = 500-650 nm) and 
MeRho (20 µM, λex = 476 nm, λem = 480-650 nm) fluorescence in aqueous solution at 
various pH (100 mM KCl), b) Proposed protonation/deprotonation transitions of MeRho 
and fluorescein at various pH. 
 
 
 
  
 
Table A.1. Tabulated detection limit data of toward H2S. Conditions: 5 µM MeRho-Az, 
PIPES buffer (50 mM, 100 mM KCl, pH 7.4), λex = 476 nm, λem = 480-650 nm, 37 °C. 
Each concentration represents the average of at least three trials. 
 
[H2S] (µM) Integrated Fluorescence Standard Deviation 
Blank 612234 141173 
0.10 1093559 74073 
2.5 13564824 2539964 
5.0 24469632 4032106 
7.5 30622452 4228960 
15 58199116 8051924 
a) 
b) 
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Figure A.3. a) Fluorescent response of MeRho-Az to H2S released from DATS with 
various [GSH] over 90 minutes. Conditions: 5 µM MeRho-Az, 300 µM DATS, 50-500 
µM GSH, PIPES buffer (50 mM, 100 mM KCl, pH 7.4), λex = 476 nm, λem = 480-650 
nm, 37 °C, b) Linear relationship between observed fluorescence turn-on from H2S 
release and [GSH]. 
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APPENDIX C 
CHAPTER IV SUPPLEMENTARY INFORMATION AND SPECTRA 
 
Supplementary Figures 
 
 
Scheme C.1. Resonance contribution in ADT-OH and ADT-NH2 from lone pair 
delocalization. 
 
 
Figure C.1. HPLC analysis of a) ADT-NH2, ADT-NAc, and the reaction products of 
ADT-NAc hydrolysis, b) ADT-OH, ADT-OAc, and the reaction products of ADT-OAc 
hydrolysis. Conditions: 20 µM analyte, 18 hour hydrolysis in 0.1 M HCl, 
H2O:acetonitrile eluent gradient from 4 to 100 % with 10 mM triethylammonium acetate. 
Hydrolysis of ADT-OAc does not appear to be entirely clean, as a reaction byproduct 
was also observed on HPLC. 
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(3-thioxo-3H-1,2-dithiol-5-yl)phenyl)pentanamide (ADT-NVal) 
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APPENDIX D 
CHAPTER V SUPPLEMENTARY INFORMATION AND SPECTRA 
 
Supplementary Figures 
 
 
Figure D.1. Aqueous stability and thiol dependent H2S release from (NAC)2S4. Electrode 
signal was allowed to equilibrate for 15 minutes after injection of (NAC)2S4 (10 µM) into 
PBS buffer (pH 7.4, 1 mM CTAB) while no H2S was observed. Immediately after GSH 
injection (500 µM), H2S release was observed from tetrasulfide. 
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Figure D.2. H2S release rates of tetrasulfide derivatives. Alkyl tetrasulfides (NAC)2S4, 
(PCys)2S4 and p-functionalized aryl tetrasulfides containing –OMe, –F, –Me, –NMe2, and 
–NO2 substituents (10 µM) were treated with GSH (100 µM) in PBS buffer (pH 7.4, 1 
mM CTAB), and the H2S release was observed over 90 minutes. 
 
 
Figure D.3. Conversion of (NO2Ph)2S4, 7, to p-nitrothiophenol after reaction with GSH. 
a) UV-vis spectra of (NO2Ph)2S4 (10 µM) before (green) and after (red) treatment with 
GSH (100 µM) in PBS buffer (pH 7.4, 1 mM CTAB) overlaid with the UV-vis spectrum 
of p-nitrothiophenol (20 µM, blue), b) Normalized appearance of p-nitrothiophenol 
absorbance at 431 nm (red) and electrode signal for H2S release (blue). 
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1
H NMR (500 MHz, CDCl3) of 1,4-Bis(4-methoxyphenyl)tetrasulfane (4) 
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H NMR (500 MHz, CDCl3) of 1,4-Bis(4-fluorophenyl)tetrasulfane (6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
1
H NMR (500 MHz, CDCl3) and 
13
C{
1
H} NMR (125 MHz, CDCl3) of 1,4-Bis(4-
nitrophenyl)tetrasulfane (7) 
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